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INTRODUCTION 
          The word Siddha comes from the word Siddhi which means an object to 
attain perfection or heaven. The Siddha system is of Dravidian origin and has its entire 
literature in Tamil language. This system of medicine was developed by the 18 ancient 
saints who were known by the name "Siddhars" whose life goal was to attain salvation. 
The Siddha system of medicine uses a fascinating combination of herbs, minerals, metals 
and to promote good health and longevity.  
“AiPj§p Es[úR ©iPm 
©iPj§p Es[úR AiPm 
AiPØm ©iPØm Juú\ 
A±kÕ Rôu TôodÏmúTôúR” 
 - NhPØ² Oô]m. 
                        Siddha science considers nature and man as essentially one. "NATURE IS 
MAN AND MAN IS NATURE". Man is said to be the microcosm and Universe is the 
macrocosm because what exists in the world exists in man. Man is nothing but a 
miniature world containing the five elements of the various principles which constitute 
the, vegetables and the animal kingdom. 
“RXeLôh¥«ÚkRf NPUô] ûYméRm 
¨XeLôh¥ ¿oLôh¥ ¨u±Úk ¾Lôh¥ 
YXeLôh¥ YôÙYôp Y[okúR «ÚkR 
              ÏXeLôh¥ Yô²t Ï¥Vô«ÚkRúR 
CÚk§Óªq ûYkRôùXÓjR NPªÕ”    
                                                                §ÚêXo Sô¥ 
“¨Xk ¾ ¿o Y° ®ÑmúTôûPkÕm 
LXkR UVdLm EXLUôR­u” 
                                                        ùRôpLôl©Vm. 
 
  According to Siddha medical science, the  Universe originally consisted of atoms 
which contributed to the five basic elements, viz., earth, water, fire, air and sky which 
correspond to the organs of the human body and they were the fundamentals of all the 
corporeal things in the world.  
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“EPmTôo A¯«u E«Wôo A¯Yo 
§PmTP ùUnOô]m úNWÜm UôhPôo 
EPmûT Y[odÏm ETôVm A±kúR 
EPmûT Y[ojúRu E«oY[oj úRú] “ 
  §ÚUk§Wm. 
                        It worked on the basic concept that a healthy soul can only be developed 
through a healthy body. According to Siddha system, the human body is composed of 96 
principles,(thaththuvas) 72,000 blood vessels(naadikal) and 1,300 nerves (Nerves). 
Besides these, there are 10 Nadi (main arteries),10 Vayu (vital pranas) and 14 Vegangal 
(natural functions). 
 The food is considered to be basic building material of human body, which 
gets processed into blood, tissues and wastes. The equilibrium of blood, body tissues and 
waste products is considered as health and its disturbance or imbalance leads to disease or 
pathologic state. So the siddhars developed methods and medication that are believed to 
strengthen their physical body and thereby their souls. The system not only deals with 
medicine, but with spirituality, righteous way of living, rejuvenation and its main aim, 
Attainment of Perfection. 
The main benefits of siddha system includes, 
It treats the disease to its roots, without leaving any traces for it to reappear.  
The medicines are made from natural materials. 
   It is considerably a cheaper form of treatment.  
The treatment has to be individualized with far less chances of committing mistakes in 
diagnosis of treatment.  
 Pandu Noi ( Iron deficiency anemia (IDA) ) is the single most common 
disorder affecting mankind. It is estimated that more than 2 billion people suffer from 
IDA worldwide. It is seen in all parts of the world - developed as well as developing 
countries. In India nearly 70% of children are estimated to be anemic patients due to iron 
deficiency. During the past two decades great advances have been made in the knowledge 
of iron deficiency anemia and the relation of dietary deficiencies in the formation of 
blood.  
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 There are many types of anemia. Iron deficiency anemia is a decrease in 
the number of red blood cells in the blood due to  lack of iron. The risk of iron deficiency 
anemia is high during the second year of life because of increased iron requirements 
related to rapid growth. Premature and low birth weight infants and infants with history of 
prolonged stay in the neonatal unit are at particularly high risk of developing iron 
deficiency anemia before 1 year of age.  
 Iron deficiency anemia affects neurological development by decreasing 
learning ability, altering motor functions, and permanently reducing the number of 
dopamine receptors and serotonin levels. Iron deficiency during development can lead to 
reduced myelination of the spinal cord, as well as a change in myelin composition.  
 
  Every age group is vulnerable to iron-deficiency anaemia. In children, anaemia 
can cause a 5-10 point deficiency in IQ and hamper growth and language development. 
 "Anaemia is causing red alert for Indian women and children and we need 
to address it.  In India, besides focussing on prevention, The author need to talk of the 
disease Pandu noi (IDA) and the treatment of rampant anaemia to address health, 
education and economic consequences due to anaemia," 
 
 So this dissertation focuses the treatment for pandu noi ( Iron deficiency 
Anaemia (IDA) ) that is, a safe and simple drug TIRUDHARATCHATHA 
CHOORANAM(TC) by Agasthiyar vaithiya rathinachurukkam, which gone through a 
thorough  literature review of siddha texts books about Biochemical, Pharmacological and 
Preclinical study, Clinical trials were carried out and the result obtained were discussed in 
the end.  
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AIM AND OBJECTIVES 
AIM: 
The aim of this study on pandu noi is to ensure a new approach in diagnosis for 
the disease and find out a safe and simple drug. It is essential to find out a safe and simple 
drug to over come Pandu noi. The drug should be easily available, economic, easily 
administered and also easily palatable. 
 
OBJECTIVES :  
1. To collect various school of thoughts regording pandu noi mentioned in various 
siddha literatures. 
2. To know the extend of correlation of etiology, signs and symptoms of pandu noi with 
anaemia. 
3. To analyse and review the disease pandu on the basis of its affection on various 
organ systems. 
4. To utilize the diagnostic methods mentioned by siddhars. 
5. To correlate the relation between pandu noi and seasonal variations. 
6. To study the age-sex ratio, socio economic status for the disease. 
7. To study about the predisposing factors contributing to this disease. 
8. To conduct a pilot clinical trial with TIRUDHARATCHATHA 
CHOORANAM(TC)  
9. To study pharmacological and Bio-chemical analysis of the trial drug. 
10. To utilize the modern parameters of investigation for the confirmation of the disease 
and to follow the prognosis. 
11. To make an awareness among the parents about the prevention of the disease in 
children. 
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REVIEW OF LITERATURE 
SIDDHA ASPECTS 
Siddha literatures deal with classification of diseases mainly by mukkutra theory 
that is Vaatham, Pitham and Kabam.  
Disease is defined as cause and effect due to the alterations made by food and 
activities performed in Sookshma and Sthoola bodies. 
"E«o RôÕ, EPp RôÕ B¡VYt±p EQYô§ ùNVpL[ôp HtTÓm Uôt\eL°u 
LôWQ Lô¬VúU úSôn "G]lTÓm. 
So these texts provide us with a line of treatment of both Sookshma and Sthoola 
bodies. 
 Pandu noi is caused by derangement of Pitham. Hence the basic details regarding 
Pitham is briefly explained before going into the study  about Pandu noi.  
 
Mukkutra Theory of Pitham : 
Pitham (Azhal) is one of the three vital phenomena (Vaatham, Pitham, Kabam). 
Among the panchaboodhas, it is formed by the Theyu bootham. In healthy individuals, 
the existance of the three humours are found  in the ratio of  1 : ½ : ¼ respectively. This is 
explained as  
 “ùUnV[Ü YôRùUôuß úUp ©jRúUôWûWVm 
IVe LôùXuú\ A±” 
           LiÔNôªVm 
This ratio is altered when there is disturbance to Pitha dhosham, which leads to 
alteration of Pitham leading to Pitha diseases. 
 
Location of  Pitham  in the Body 
· Pingalai 
· Praanavayu 
· Neerpai 
· Moolakkini 
· Irudhayam 
· Thalai 
· Kopuzh 
· Undhi 
· Iraippai 
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· Viyarvai 
· Naavil oorukindra neer 
· Senner 
· Saaram 
· Kan 
· Thol 
 
More over, 
As per Thirumoolar’s thought, 
 “©¬k§Óm ©jRm úTWôgNXj§²p” 
As per Yugimuni’s thought 
 “úTôùUu\ ©jRjÕd¡Úl©PúU úL[ôn 
 úTWô] LiPj§u ¸ZRôÏm.” 
 
General Characters of Pitham. 
· Veppam (Heat) 
· Koormai (Sharpness) 
· Neippu (Lubricative) 
· Nekizhchi (Elastic) 
· Pitham gets the properties of the substance to which it combines. 
 
Natural Properties of Pitham : 
· Seripithal (Digestion) 
· Vanmai (Strong) 
· Vemmai (Heat) 
· Menmai (Soft) 
· Paarvai (Sight)   
· Pasi (Hunger) 
· Neervetkai (Thirst) 
· Suvai (Taste) 
· Oli  (Light) 
· Ninaippu (Thinking) 
· Arivu (Knowledge) 
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Own qualities of Pitham – 6   Opposite qualities of Pitham – 6 
Hot  -  Ad¡²  Cold   - Ï°of£ 
Acidic  - ×°l×   Sweet   - C²l× 
Mobile  - FÚkRuûU  Immobile  - ¨ûXj§ÚjRp 
Liquid  - NXìTm  Solid   - ùLh¥ 
Acute  - ÏìWm   Mild or Harmless  - NôkRm 
Pungent - LôWm   Bitter   - LNl× 
 
Functions of Pitham : 
1. Raising the body’s temperature 
2. Giving red or yellow colour to the body 
3. Raising the body temperature during digestion and assimilation 
4. Produces perspiration, giddiness. 
5. Raising the volume of blood and its expulsion 
6. Gives yellow stain to eye, motion and urine. 
7. Anger, irresponsible, immobile, thoughtfulness, excitement, thinness. 
8. Feeling of irritation. 
9. All tastes like sour, bitter. 
 
Some illustrations of Pitham: 
 Gross body  - Chest and abdomen 
 Systems  - Digestive, circulatory 
 Functions  - Vital 
 Gunaas  - Rajasic 
 Cell   - Protoplasm 
 Humours  - Gastric Juice 
 Excretions  - Perspiration, Urine 
 Expulsion of dhosha - Watery or yellowish discharge 
 Feeling of dhosha - Heat 
 Classification  - Inflammation 
 Causes   - Low vitality 
 Treatment  - Stimulation 
 Nature   - Sun 
 Shape   - Liquid 
 Profession  - Police 
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Formation of Senneer : 
During the process of digestion in our body, Saaram or Rasa thathu (Chyle) is 
formed on the first day. From saaram, Senneer (blood) is formed on the second day. From 
senneer, Oon (muscle) is formed. From oon, Kozhuppu (fat)  is formed. Enbu (bone) is 
formed from kozhuppu. From enbu, Moolai (bone marrow) is formed. From moolai, 
Sukkilam (sperm) or Suronitham (ovum) is formed on the third, fourth, fifth, sixth and 
seventh day respectively. The nutrients absorbed after digestion is responsible for the 
metabolic function of blood. 
Day 1  - Saaram (Chyle) 
Day 2  - Senneer (Blood) 
Day 3  - Oon (Muscle) 
Day 4  - Kozhuppu (Fat) 
Day 5  - Enbu (Bone) 
Day 6  - Moolai (Bone marrow) 
Day 7  - Sukkilam (Sperm)/ Suronitham (Ovum) 
 
It is to be noted that the nutrients absorbed after digestion are responsible for the 
formation of muscular, adipose and nervous tissues and calcification of bones. As saaram 
and senneer are the primary important thathus of the body, they get deranged themselves 
followed by affection of other thathus. 
 
In Pandu noi, saaram and senneer thathu are mainly affected. Saaram (Rasam) is 
affected and is noticed by the symptoms like excessive thirst, dryness of skin, tongue, 
throat and loss of body weight. 
 
Senneer is affected and is noted by the symptoms like pallor of the skin, excessive 
intake of foodstuffs having sour and acrid taste and results in general debility. 
 
Physiological aspects of Pitham : 
Our body is made up of seven udal thathus namely saaram, senneer, oon, 
kozhuppu, enbu, moolai, sukkilam / suronitham. These seven thathus constitute the body 
in normal condition. Senneer has the characteristics of pitham and it gives life to each cell 
and tissue of the body. Blood is the only vehicle, which is concerned with anabolic and 
catabolic functions of the body. 
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 Among the seven thathus, senneer is considered as pitham, which has the 
character of Thee (Theyu). Circulation and digestion represent Thee in the body. It makes 
the form of the body steady and gives vigour and stimulation. Pitham represents gastric 
juice, bile, energy, heat, inflammation, anger, irritation etc. Physiological representation 
and types of pitham in the body are given below. 
 
Relationship of pitham with taste : 
Salt  - Water + Fire  
Sour  - Earth + Fire 
Pungent - Air + Fire  
Salt, sour and pungent increases pitham since they are formed by fire (heat) . So 
they Possess Veppa Veeriyam. 
“×°ÕYo ®gÑeL± Vôoé¬dÏm YôRm 
J°ÙYo ûLlúT±p ©jÕfºßm  ¡°ùUô¯úV 
Lôol©²l× ®g£t LTm®gÑ gNh¥WRf 
úNWl ×Qo úSôVÔLôúR. “   
- LiÔNôªVm. 
 
Astringent, sweet and bitter tastes neutralize pitham since these tastes do not 
contain Agni. Hence they possess Seedha Veeriyam. 
Astringent   - Earth + Air 
Sweet   - Earth + Water 
Bitter   - Sky  + Air 
 
 “©jRU§ L¬l©u úTÑm T¬LôWm 
ÑjRj ÕYúWôÓ ùNôp­²l×f  NjRôÏm 
ûLl×f ÑûYúV LÚÕYRu Åß 
GnlTTûPÙ ùUußûWjRô ¬eÏ. ” 
- LiÔNôªVm.  
 
Aggravation of pitham in daily routine 
Pitham in raised at the time of 10 a.m to 2 p.m and 10 p.m to 2 a.m 
“LôûX«p YôRSô¥ L¥ûL«p TjRôÏm 
TôûX«p ©jRSô¥ TLÚf£ TjRôÏm 
UôûXVôm úNjÕU Sô¥ U§l×Pu TjRôÏm 
YôûXVô Uú]ôuU¦dÏ YÏjÕúU ùRôÏjRRôúU. ” 
 ûYj§V NôW Ne¡WLm.  
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Aggravation of pitham in week days 
If pitha gets aggravated at morning hours of  
Sunday 
Tuesday 
Saturday and  
Krishna patcham Thursday, 
the vigour and vitality of body is maintained. 
 
Physiologically the types of alterations of Pitham are, 
Thannilai Valarchi 
 
Definition  
Provoked kutram in its own locations is called Thannilai Valarchi. 
Limitations  
Hatefulness of the things causing Thannilai Valarchi and likeliness of the things 
having opposite properties. 
Duration  
Pitham gets Thannilai Valarchi during Kaarkaalam (Avani – Purattasi) 
 
Vetrunilai Valarchi 
Definition 
Provoked kutram to other locations is called vetrunilai valarchi. 
Limitations 
Signs and symptoms of the affected kutram and the pathological conditions of the 
udal thathukkal give the detail of limitations. 
Duration  
Pitham gets vetrunilai valarchi during Koothirkaalam (Ayppasi, Kaarthigai) 
 
Thannilai Adaithal 
Provoked kutram neutralizing its own property is called Thannilai adaithal. 
Duration 
Provoked pitham neutralizes during Munpani kaalam (Margazhi, Thai) 
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Dietic Factors which alter Pitham 
1. When cold foods are mixed with pitham, it gets Thannilai Valarchi 
2. When hot foods are mixed with pitham, pitham gets vetrunilai valarchi. 
3. When cold and indigestible foods are taken with pitham, it neutralizes its own 
property i.e. returns to healthy conditions. 
 
This is illustrated by 
“Uk§¬l Ti×Pu Ï°of£ RÚm 
YvjÕdLs ùLôi¥P XZ­PjúR 
Yk§Óm Yu©¦ AûYR²V 
Ut±PjÕm S­Ùt ±ÓúU 
UkRØk RuûUÙ ªûQk §¥Xô  
Utù\ôÚ úSô«pûX U²RÚdúL 
Ck§[ ùSt±« ù]¯XQeúL 
Ck§[ £jR¬u ùUô¯«ÕúY. ” 
                                 £jR UÚjÕYôeLf ÑÚdLm. 
 
PANDU NOI 
 
VERU PEYARKAL (SYNONYMS) : 
Veluppu noi, Venmai noi, Venpaandam. 
 
IYAL (DEFINITION) : 
Pandu noi is a disease of Raththa thathu, characterized by pallor of skin, nails, 
conjunctiva and tongue. 
 “úRLj§u CWjRj§p Es[ £YkR AÔdLs Ïû\kÕ úRLm 
ùYÞjÕ®ÓYRtÏ TôiÓ úSôn Guß ùTVo. ” 
- ALj§Vo ûYj§V ©sû[jRªr 
 
The great Siddhar Agathiyar defined pandu in the following verses. 
“L¯YôÏkR úRLUlTô LôQjRN YjRôn 
Yt±®Ó Uu]YôNp úLh¡p 
T¯LôWo ØLj§p Ø¯Vôo úTôúX TôiPùUpXôm 
ùYÞdL¥jRÕ CWjRm. ” 
   ALj§Vo ûYj§V Lô®Vm  
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“úRLj§p CWjRm Yt±j 
¾eLô] ®kR úSôn LôÔUlTô. ” 
    ALj§Vo ÏQYôLPm. 
“EPp T£V ¨\Uôn T[T[jÕ, ØLeÏÞlûT«hÓ CÚ®¯Ùm ¿X ¨\Uôn, 
CÓl×d ÏjúRôÓ, ¿Úm ùTôu²\Uôn C\eÏYúR Tôi¥u ÏQUôÏm. ” 
        E«o LôdÏm £jR UÚjÕYm. 
 
According to Siddha Maruthuvam (Gurusamy Mudaliyar) 
“¾dÏt\m ªÏkÕ ÏÚ§«u ¨\jûRÙm GûPûVÙm ùLÓjÕ EPÛdÏ úYi¥V 
FhPjûRÙm ùLôPôUp EPûX ùYÞdLf ùNnÙm úSôn”. 
 
NOI VARUM VAZHI (ETIOLOGY) : 
According to Balavagadam, the etiology of Pandu noi is given as below 
“©\kRSôs ©sû[dÏj Rôú] Su\ôn 
©RôYôúX ©¦ÙP­u úUúX úRôußm ........................ 
L]XÕ ùUjRd LôÔm LiQÕ ùYÞdÏk Rôú] 
¦ÅÙò¾¢Î ØRÓ Rôàm ........................................ 
Pandu noi may be inherited from the parents. It may be due to genetic factors. 
 
According to Yugimuni  the cause of Pandu are as follows, 
“A±kÕúU EtTj§ ùNôpXd úL[ôn 
A§NôW UXª[¡ ùVkúS WkRôu 
©±kÕúU ×°Ùl× ùTÚjRXôÛm 
ùTjRUô Ud¡² «ÚjRXôÛm 
............................................................................ 
T±kÕúU TLp ¨j§ûWúV ùNnRôÛm 
À¡ñÎ YkÕ Tô¬Ûsú[ôo TÓm TôúP. ” 
                                            ë¡ûYj§V £kRôU¦. 
From the above mentioned lines, it is clear that frequent attacks of diarrhoea, 
excessive intake of salt and sour food, living in hot surroundings, excessive chewing of 
pan and nuts excessive in take of alcohol, sleeping in day time are some of the behaviors 
causing Pandu noi. 
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According to Agasthiyar Gunavaagadam, 
“ùLôs[Pô ATdÏY úTôN]j §]ôÛm 
  ......................................................¡Wô¦VôÛm 
A[Yt\® NôWkRô] ûPÙm úTôÕm 
ùRs[úY úRLj§p CWjRm ùLhÓ  
ùR°Yô] TôiPÕÜ ØiPôm TôúW.” 
 ALj§Vo ÏQYôLPm. 
Inadequate cooking of foods, negligence in the treatment of diarrhoea, profuse 
bleeding, excessive sorrows lead to Pandu noi. 
 
According to Theraiyar  vagadam 
“ RôL Øßm T£Vôp RôØiQô WôUô¡p 
úLôRÚ¿o RôLjRôt ùLôs[ôWôn  úTôR 
ªWjRk Rû]dÏ¥dÏm ªuT®Pôn úTôdÏm 
TÚjR ®¯ÏÚPôm Tôo” 
Negligence of food and water causes pandu noi. 
 
According to Thanvathiri vaithyam, 
“§Úk§Óm À¡ñÎ úWôLg úNok§Óe ÏQjûRd úL[ôn 
CÚk§Óm YôR©jRf £úXtT] ªûYRôu Uôßm 
×¬kÕRô ù]ôuú\ôùPôuß ùTôÚkÕYRôÛ UiúQô 
PÚkÕYRôÛm À¡ñÎ YûQk§Ó ùUu]XôúU. ” 
“B¡V êXk Ru²XûQkR ÜhPQj§]ôÛk 
úRôûLVo úULjRôÛm ÕVoªÏ úWôLjRôÛm 
úRL úTô`ûQ Ùsú[ôodÏj R¬j§Wg úNoRXôÛm 
úYLUôk §¬úRô`eLs ªg£V TôiÓ YôúU. ” 
- RuYk§¬ ûYj§Vm. 
Imbalace between the three thathus, vatham, pitham, kabam, perversion of 
appetite such as eating mud (PICA), excessive heat accumulation due to altered Abana 
vayu, excessive sorrow, psychosocial factors are some of the causes of pandu. 
 
Due to worm infestation : 
According to Gurunaadi, 
“YVp R²úX éSôL UiûQjRôú] 
YÚk§VÕ ×jÕlúTôX YjûRVôÏm 
TVpùUôÆ ÂoúRLj§p ¡ÚªRôú]. ” 
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Pathologically, blood loss occurs due to several causes. One among them is worm 
infestation, which leads to chronic blood loss from the intestines thus leading to anaemia. 
 
Imbalace between the three thathus, vatham, pitham, kabam, perversion of 
appetite such as eating mud (PICA), excessive heat accumulation due to altered Abana 
vayu, excessive sorrow, psychosocial factors are some of the causes of pandu. 
 
Due to worm infestation : 
 
According to Gurunaadi, 
“YVp R²úX éSôL UiûQjRôú] 
YÚk§VÕ ×jÕlúTôX YjûRVôÏm 
TVpùUôÆ ÂoúRLj§p ¡ÚªRôú].” 
Pathologically, blood loss occurs due to several causes. One among them is worm 
infestation, which leads to chronic blood loss from the intestines thus leading to anaemia. 
According to Thanvathiri vaithyam, 
 
“§Úk§Óm À¡ñÎ úWôLg úNok§Óe ÏQjûRd úL[ôn 
CÚk§Óm YôR©jRf £úXtT] ªûYRôu Uôßm 
×¬kÕRô ù]ôuú\ôùPôuß ùTôÚkÕYRôÛ UiúQô 
PÚkÕYRôÛm À¡ñÎ YûQk§Ó ùUu]XôúU. ” 
“B¡V êXk Ru²XûQkR ÜhPQj§]ôÛk 
úRôûLVo úULjRôÛm ÕVoªÏ úWôLjRôÛm 
úRL úTô`ûQ Ùsú[ôodÏj R¬j§Wg úNoRXôÛm 
úYLUôk §¬úRô`eLs ªg£V TôiÓ YôúU. ” 
 RuYk§¬ ûYj§Vm. 
 
Imbalace between the three thathus, vatham, pitham, kabam, perversion of 
appetite such as eating mud (PICA), excessive heat accumulation due to altered Abana 
vayu, excessive sorrow, psychosocial factors are some of the causes of pandu. 
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Due to worm infestation : 
According to Gurunaadi, 
“YVp R²úX éSôL UiûQjRôú] 
YÚk§VÕ ×jÕlúTôX YjûRVôÏm 
TVpùUôÆ ÂoúRLj§p ¡ÚªRôú]. ” 
 
Pathologically, blood loss occurs due to several causes. One among them is worm 
infestation, which leads to chronic blood loss from the intestines thus leading to anaemia. 
 
 “¡ÚªVôp YkRúRôPm ùTÚLÜiÓ 
úLhLY§u ©¬YRû] ¡WUUôL 
................................................................................... 
úRLU§p úNôûLd ÏhPe ¡ÚªVôúX ” 
 ÏÚSô¥ èp. 
According to this, sogai will occur due to worm infestation, which meant Pandu 
noi. 
 
Due to Toxicity: 
1. “Tj§] «WR úRôPm À¡ñÎYôm úU² ùVpXôm 
.................................................................................. 
©jRØ U§L Uô¡l ©WXôT UôLl úTÑm  
Tj§V «WR úRôPd ÏQùU]l TLWXôúU ” 
    Due to impure mercury pandu noi will occur. 
2. Over dose of phosphorous, lead, copper sulphate produce the symptoms of pandu. 
3. Chronic use of white arsenic produce the symptoms of pandu. 
 
NOI ENN (CLASSIFICATION): 
According to Yugimuni  Pandu noi is classified into 5 types 
“á\úY TôiÓ ®Pl ùTVûWd úL[ôn 
Ï±lTôL ûYkÕ®R UôÏm TôÚ 
YôWúY YôRUôm Tôi¥ ú]ôÓ 
UôodLUôm ©jRj§u TôiÓ Rôàm 
úR\úY £úXhÓUôm TôiÓ Rôàm 
§¬úRôPl TôiúPôÓ ®P TôiPôÏm ” 
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Thanvanthiri classified pandu into 7 types 
“T«j§V TôiÓ YôRTôiÓúY £úXjÕm TôiÓ 
 ®Vj§¬ úRô`lTôiÓ ùYßm ©jR £úXjÕm TôiÓ 
T«j§V YôRTôiÓ TLo Nu²YôR TôiÓ 
 SVl×ßm TôiÓ úY¯u ÏQjûR Sôu S®XÛtú\u” 
RuYk§¬ ûYj§Vm. 
 
Classification of Pandu noi based on various Siddha books. 
 
AGASTHIAR GUNAVAAGADAM        VAITHYASARASANKRAHAM 
1. Vatha pandu    1. Vatha pandu 
2. Pitha pandu     2. Pitha pandu 
3. Kaba pandu     3. Moola pandu 
4. Vida  pandu     4. Moolapitha pandu 
5. Mukkutra pandu    5. Vida pandu 
  
YUGI CHINTHAMANI-800   T.V. SAMBASIVAM PILLAI 
ROGA NIRNAYA SAARAM 
1. Vatha pandu    1. Vatha pandu 
2. Pitha pandu     2. Pitha pandu 
3. Kaba pandu     3. Kaba pandu 
4. Mukkutra pandu    4. Mukkutra pandu 
5. Vida pandu     5. Oothu pandu 
       6. Neer pandu 
       7. Eri pandu 
       8. Vida pandu 
 
THANVANTHIRI VAITHIYAM     ANUBA VAITHIYA DEVA RAGASIUM 
1. Vatha pandu    1. Vatha pandu 
2. Pitha pandu     2. Pitha pandu 
3. Kaba pandu     3. Kaba pandu 
4. Mukkutra pandu    4. Mukkutra pandu 
5. Pitha vatha pandu    5.Miruthikapuktha pandu 
6. Sannipatha pandu    6. Vida pandu 
7. Paithiya pandu 
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PARARASA SEKARAM    MADAVA NITHANAM 
1. Vatha pandu    1. Vatha pandu 
2. Pitha pandu     2. Pitha pandu 
3. Kaba pandu     3. Kaba pandu 
4. Sanni pandu    4. Sanni pandu 
5. Miruthika pandu    5. Mann pandu 
 
JEEVARAKSHAMIRTHAM   ASHTANGA HRIDAYAM 
1. Vatha pandu    1. Vatha pandu 
2. Pitha pandu     2. Pitha pandu 
3. Kaba pandu     3. Kaba pandu 
4. Tridosha pandu    4. Sanni patha pandu 
5. Miruthikapuktha pandu   5. Mannun pandu 
 
KURIKUNANGAL IN PANDU NOI (CLINICAL FEATURES) 
 
1. Murkurikunangal (Premonitory symptoms) 
Pandu patients exhibit the following symptoms from their initial stage of 
development itself. The patient experiences insidious onset of fatiguability, dyspnoea on 
exertion, diminished vision, faintness, palpitation and pallor of the skin. 
 
Theraiyar Neerkkuri illustrates that,  
“CVtûL ¿o ÑÚe¡àm CÕÜm NXlùTôÚs 
ùNVtûL VôVÚk§àm £ßjR ¿¬ÕÜm 
TôiÓ úSônf NmTYjûRj RÚª§p” 
 
Oliguria occurring suddenly and oliguria occurring even after excessive intake of 
water are explained as premonitory symptom of pandu noi. 
 
Manmurugiam Ennum Tamil Maruthuva nool states that 
 “A¥dL¥ EªrRp BdûL R[oRp 
 ¿Úm LNÓm UgNs ¨\mTPp 
 ùSgNd L¬l× ùSÓkúRôp ùY¥jRp 
 Li¦ûU R¥jRp EiPR ÚûU 
 Ui§u ±ÓRp ®VojRp ©\Üm 
 ùY°tß úSô«u Øu]RôÏm” 
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The above mentioned lines explains the premonitory symptoms of pandu as 
excessive salivation, tiredness, yellow colour urine, fissured skin, thickening of eyelids, 
pica i.e., eating mud and excessive sweating. 
 
 POTHU KURIGUNANGAL (GENERAL SIGNS AND SYMPTOMS) 
Agasthiyar Gunavaagadam states that, 
“EiPôÏm úYû[ Ru²p úRL úSoûU 
 Eß§Vônf ùNôpÛ¡ú\u Su\ôn TôÚ 
ÏiPô] ØLm LiLs ERÓ SôdÏ 
 Ï±lTô] Yôn úYÏm úRL Øtßm 
ùYiPôL úYÙXokÕ ùYiûU Vô¡ 
 ®Wp LôpLs ØÝY§Ûm WjRm Yt± 
LiPô] LôpLs Rôu R¦kÕ ¨tÏm 
 LÚYô] Sô¥VÕ ùUÕYônl úTôúU. 
úTôúU Rôu ¾T]eLs UhÓlThÓ 
  
ùTô­Yô] Li®¯Ls ùTÚjÕj úRôußm 
BúU Rôu ANd§Ù UôVôNe LiÓ 
 AYo SûPÙm R[okÕ ùTÚêfÑ LiÓ 
êúURôu êofûNÙPu UôoÕ¥jÕ 
 Ø¥Yô] LÔdLô­p ÅdLØiPôn 
RôúU Rô²ÚRVj§u YR]k Ru²t 
 ÕÚj§ ¨Lo NjRUÕ úLhÏm TôúW” 
 ALj§Vo ÏQYôLPm. 
Stomatitis, dryness of the skin, pallor of the face, eyes, lips, tongue and nails, 
lassitude, tiredness, low volume pulse, anorexia, swelling of the eyelids, dyspnoea on 
exertion, palpitation, oedema of the ankle joint, added heart sounds in the precordium are 
mentioned as the signs and symptoms of pandu noi. 
 
Agathiyar Vaithiya Rathna Churukkam states that, 
“©jRj§t ©jRUô¡p ©Rt±Óm ¡ß¡ßl× 
Nj§V U§LUôÏm NÃWj§­û[l ×iPôÏm 
Aj§Vô ÙXÚúU² VôLØm úY\RôÏm 
Yj§úV ùYÞjÕd LôVm Y\iÓ ©u ÅdLØiPôÏm” 
Giddiness, emaciation pallor of the body are mentioned as symptoms of pandu noi. 
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Vaithiya Vilakkam Ennum Amirthasagaram states, 
“ALh¥²p YôÙÜiPô UÚk§V Üi¥ SôÞm 
ªLf ùN¬VôûU ¨tÏ Á[Üm ×WÞùUuL 
ùYÏj§Ó ®R]e LôhÓ ùUn Li ûLRôu ùYÞdÏm 
ªLfNX UXjûR LhÓ úU²úY \ôÏk Rôú] 
SWm©u Y¯VRôL SPkùReÏm TWkÕ Pm©u 
¨Wm©V UgN½o úTô ÛhPQ ¨LÝg ºRm 
YWm©X RôÏ Uu± UôoùTôÓ Y«ß UkRd  
LWm×\kRô[ ûRdÏe L§j§Ó êfÑ UhÓm 
ùYnVúTô N]eLs úYiÓ ÁiPûY ÙiQ ùYôhPô 
ùUn ªà ªàl×d ùLôsÞm úYßg ùNn ÏQeLÞiPôm 
ûTÙs ùNn TôiÓ úWôLm Tôt±Ú URàdúLt\ 
ùNnV Su UÚkÕ Ruû]j §\mTP ®²Õ úLiªu” 
 
Flatulence, indigestion, pallor of the conjunctiva and skin, anuria, constipation, 
dyspnoea, loss of appetite, glistening of the skin. 
 
In Siddha maruthuvam, Gurusamy mudaliar states , 
 
Inability to walk, headache, palpitation, blurring of vision, giddiness, syncope, 
dyspnoea, anorexia, vomiting, paleness of the skin, nailbeds become swollen and pallor, 
fissured tongue, glossitis, hoarseness of voice. 
In females scanty menstruation, sometimes menorrhagia may occur. 
If it occurs in pitha thegi, anorexia, indigestion, burning  sensation, pallor of skin, 
glossitis, dysphagia, vomiting with bile, bitter taste and diarrhoea occurs. If the symptoms 
persist for longer duration it results in jaundice. 
 
According to Vaithya Sarasankraham, 
Loss of appetite, thirst, pallor of the skin, lips, eyes and tongue, face becomes dry 
due to excessive heat, flatulence, swelling and pain in lower extremities. 
 
According to Sarabendrar Vaithya Muraigal – Karbini Balaroga Chikitchai 
Y«t±úX JúW NU]ô] ÅdLm, LiLs, SLm ØR­V] ùYÞjRp, LiL°p 
ÅdLm, T£«uûU ØR­V] LôQlTÓm. 
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SYMPTOMS OF VARIOUS TYPES OF PANDU : 
1. Vatha pandu : 
“ùLôs[úY YôR TôiÓ úWôLe úL[ôn 
ÏPp ×Wh¥V¥ Y«ßRôu Y­dÏk 
Rs[úY RôLùUôÓ T£ÙªpûX 
RZXô] NWNWl TôLjRôàm 
Ss[úY SWmùTpXôe Lßl×UôÏm 
SÓdLùXôÓ Li £Yl× UX TkRkRôu 
®s[úY RûXY­dÏ úU² ÅeÏm 
ùYÞlTôÏm YôRj§u TôiÓRôú] ” 
- ë¡Ø² 
The symptoms of Vatha pandu are lower abdominal pain, thirst, loss of appetite, 
dryness of the skin, visible veins due to pallor of the skin, redness of the eyes, 
constipation, headache, anasarca and pallor of the skin. 
2. Pitha pandu :  
“YôùUu\ úU²ùVpXô UgN°jÕ 
ULôùYÞl× EiPô¡ UkRd LiQôk 
RôùUu\ RôLùUôÓ êofûN VôÏk 
R² Yô«p ª[Ï úTôt\ô àû\dÏm 
úSùUu\ ùSgN ØsRôà ØiPôn 
ùSÚd¡úV êfÑ ØhPÕúY VôÏe 
úLôùUu\ ¡ß¡ßjÕYôn ûLlTôÏe 
¡[ol©jR TôiÓùY]d á\XôúU” 
- ë¡Ø² 
Yellowish colouration and pallor of the skin, diminished vision, thirst, fainting, 
pungent taste like pepper, chest pain, dyspnoea, giddiness and bitter taste. 
3. Kaba pandu : 
“á±VúRôo SWm× úRôp ªL ùYÞl× 
¡[o SôÜ El×û\dÏm U«o áfNôÏm 
Yô±VúRôo Yôk§Vôe ÏWÛe LmØm 
ULjRô] ÕmUÛPu úLôûZVôÏm 
D±VúRôo CÚUùXôÓ UVdLØiPôm 
CÚlTN§ «k§¬V ShPUôÏm 
º±VúRôo úNôTùUôÓ RôTUôÏg 
£úXhÓUj §uTôiùP]f ùNlTXôúU” 
ë¡Ø² 
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Pallor of the skin, salty taste, flushing of the skin, vomiting, husky voice, 
sneezing, cough with expectoration, fainting, lassitude, ejaculation of semen, anasarca 
and thirst. 
 
4. Mukkutra pandu : 
“ùNlTúY VÚ£ùVôÓ úNôTRôLg 
ùNVXô] ÑYôN ùUôÓ Cû[l×UôÏm 
ùYlTúY úUL]j§p £ß¿oRôu ÅÝm 
ªÓdLô] ùTX Å]Uôo ©¥jRp 
ÕlTúY ãhúPôÓ §VdLUôÏk 
 
ÕmUXôÙPm ùTeÏê§d LôÔk 
§lTúY úRLùUeÏ UN§VôÏm 
§¬úRôPl TôiùPu]f ùNl×m èúX” 
ë¡Ø² 
Anorexia, thrist, dyspnoea, anasarca, chest pain, lassitude, sneezing, warmness of 
the skin, weakness. 
 
5. Vida pandu : 
“èXôL SLj úRôúPÙPp ùYÞdÏm 
úSôn SWm× ãPôÏm RôLUôÏm 
BXôLVÚ£ùVôÓ Nj§ ®dLp 
ARh¥úV CÚUÛP]§ ÑYôNm 
YôXôL Y«t±ûWf NX§NôW úRôPm 
UôÑWØØiPôRp UôoL]jRp 
úYXôLúU²ùVeÏ ªLúY FRp  
®PTôiÓ ANôj§VùUuú\ ®[mTXôm. ” 
ë¡Ø² 
Pallor of the skin, excessive thirst, anorexia, vomiting, hiccough, cough, 
dyspnoea, flatulence, diarrhoea, fever, heaviness of the chest, anasarca. 
According to Thanvanthiri Vaithyam, 
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1. Vatha pandu : 
“B] Li UXNXeLs A¦SLe LßlTRôÏk 
RôLUô UeLùUeÏk R¥V¥ TÓûL úTôúX 
Á]Uôn SÓdLØiPô ªûNkR ÕoTXØØiPô 
Uô]¿o YôRTôiÓ ùYu] YÏdLXôúU. ” 
Eyes, face, urine, motion and nails are black in colour, thirst, tremor, fatigue. 
 
2. Pitha pandu : 
“Et\úRôo Au]úTRm AWôNL ØRW UkRm 
Øt± Uôol× úSôn êj§Wm ùTôu²u YuûU 
úYt± úNo ×\eLôpûL Li ÅeÏPp ùYÞjRp úYojRp 
       Tt± ùRôd¡tLôn T¦j§V TôiÓYôúU.“ 
Anorexia, flatulence, chest complaints, high coloured urine, oedema of the dorsum 
of feet and hand, perspiration and pallor of skin. 
 
THODAR NOI OF PANDU NOI (COMPLICATIONS) 
 
When the disease progresses kabam increases resulting in sobai (Oedema).  
Moreover when pandu noi is severe excessive intake of pitha diets and sexual 
intercourse lead to kamalai (jaundice). This is stated by Yugimuni as follows. 
“ ®[mTúY TôiÓ Øt±ÚdÏm úTôÕ 
Á±úV ©jRYvÕRû]l ×£jRôp 
×[mTúY UeûLÙPu ×Qof£ ùNnRôp 
éi¥ÓúU LôUôûX ùVàm úWôLm”  
ë¡ Ø². 
 
MUKKUTRA VERUPAADUGAL (PATHOLOGY) 
 
Udal vanmai is affected due to excessive intake of salt and sour foods, which 
cause indigestion and loss of appetite. This affects rasam and raththa thathus which lead 
to increase in pitham and do not give nutrition to the body affecting ranjagam leading to 
pallor of the skin. The increased pitham affects both vatham and kabam increasing the 
pallor of the skin. Further kabam increases producing generalized swelling of the body. 
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PINIYARI MURAIMAI (DIAGNOSIS) : 
 
Pini means the disease, which affects the body. 
Ari means indentify 
Muraimai means rules. 
Piniyari muraimai is the method of determination of diseases. It is based upon three main 
principles. They are 
1. Porialarithal (Inspection) 
2. Pulanalarithal (Palpation) 
3. Vinathal (Interrogation) 
 
Physicians pori and pulan are used as tools for examining the pori and pulan of the 
patient. The above principles correspond to the methodology of inspection, Palpation and 
Interrogation in modern medicine, helping the physician to arrive at a clinical diagnosis of 
the disease. 
Pori is considered as the five sense organs of perception  namely Skin, Tongue, 
Eye, Nose and Ear. 
Pulangal are five objects of senses, which are Tactile sensation, Taste, Sight, 
Smell and Sound. 
Vinathal is asking informations regarding the history of the disease, its clinical 
features from the patient or his close relatives who are taking care of the patient , when 
the patient is not in a position to speak or if the patient is a child. 
 
ENNVAGAI THERVUKAL (EIGHT TOOLS OF DIAGNOSIS) 
Ennvagai thervugal is a unique method of diagnosing the disease, which was 
developed by siddhars. 
“Sô¥lT¬Nm Sô¨\m ùUô¯®¯ 
UXm êj§WªûY UÚjÕYWôÙRm.“ 
 úSôn SôPp úSôn ØRp SôPp 
 
“ùUndÏ± ¨\m ùRô² ®¯Sô CÚUXm ûLdÏ±.“ 
  úRûWVo 
 
 
24 
 
PANDU IN RELATION WITH ENNVAGAI THERVUKAL : 
 
1. Naadi (Pulse) 
EP­p E«o R¬j§ÚlTRtÏ LôWQUô] Nd§ GÕúYô AÕúY RôÕ ApXÕ Sô¥ 
G]lTÓm. 
                                             úSôn SôPp úSôn ØRp SôPp. 
Naadi is responsible for the existence of life. It is a suitable diagnostic tool used 
by Siddhars. It is recognised as one of the principle means of diagnosis and prognosis of 
the disease from time immemorial. 
 
NAADI NADAI IN PANDU NOI : 
 
1. Pitha Naadi : 
“ BúURôu Vj§ ÑWm TôiÓ úNôûL 
..................................................................................... 
SôúURôu ùNôuú]ôúU ©jRdáß 
S®u±hPôo YôNØ² S®u±hPôúW” 
ALj§Vo 
2. Kaba Naadi : 
“ Rô]Øs[ úNjÕUkRô²[¡p ùYl× 
...................................................................................... 
H] Øße LôUûX TôiÓ úNôûT 
HÝ ÑWeLs TXÕdLm ®P ØiPôúU” 
NRLSô¥ 
3. Vatha Kaba Naadi : 
“ YôRj§p úNjÕUUô¡p Y­ùVôÓ ÅdLØiPôm 
............................................................................................................ 
¾Õtß ùUnùYÞjÕj §PØP]N]g ùNpXô” 
ALj§Vo Sô¥ 
4. Kaba Vatha Naadi : 
“ LiPôúVô £úXtT]j§p YôRSô¥ 
......................................................................................... 
®iPôúX «û[l©ÚUp úNôûT TôiÓ” 
NRLSô¥ 
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5. Kaba Pitha  Naadi : 
“ CPUô] úNjÕUj§p ©jR Sô¥ 
.................................................................................. 
ùYÏ ÑWØm SôY\h£ TôiÓ úWôLm” 
NRLSô¥ 
2. Sparisam (Palpation) : 
The warmth, chillness, dryness, roughness of the skin, oozing, sweating, 
tenderness, fissures, depigmented changes in the skin, swelling, ulcer and 
hepatosplenomegaly may be noted. 
 
3. Naa (Tongue) : 
The colour, dry or wet, coating, excessive salivation, redness, ulceration, fissure, 
pallor, any malignant growth, predominant taste in the tongue, speech, movement and 
deviation of the tongue along with the conditions of the teeth and gums should be noted. 
In Pandu noi, pallor of the tongue and loss of taste buds are seen. 
 
4. Niram (Colour) : 
Changes in the colour of the skin, teeth, eyes, nail, lips due to vatham, pitham, 
kabam and mukkutram, hypo and hyper pigmentation are noted. 
In Pandu pallor of skin, conjuctiva and nail  beds are noted. 
 
5. Mozhi (Sound) : 
This includes clarity of speech, any disturbances, high or low-pitched voice, 
slurring and incoherent speech and hoarseness of voice. 
 
6. Vizhi (Eyes) : 
Hyperemia, ulceration, response of  pupil, pallor, protrusion, sunken eyes, 
sharpness of vision, excessive lacrimation, accumulation of secretion at the angle of eyes, 
visual disturbance and any specific diseases of the eyes should be noted. 
In Pandu noi, pallor of conjuctiva is seen. 
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7. Malam (Faeces) : 
Colour, consistency, quality, smell, frequency, constipation/diarrhoea, presence of 
mucous, blood and undigested food particles in the stool should be studied. In Pandu noi, 
the following changes may be noted.  
Vatha Pandu   - Constipation 
Pitha Pandu  - Diarrhoea 
Mannun Pandu - Worms 
 
8. Moothiram (Urine) : 
Neer IIakkanam (Method of collection of urine) : 
“ A±kÕUô±WRØm A®úWôRURôn 
A@Lp AXoRp ALôXîu RYokRZt 
Ït\[YÚk§ E\e¡ ûYLû\ 
B¥dLXNj Rô®úV LôÕ ùTn 
ùRôÚ ØáojRd LûXd ÏhTÓ ¿¬u 
¨\dÏ± ùSndÏ± ¨ÚªjRp LPú]” 
 
Prior to the day of urine examination, the patient is advised to take balanced diet 
and the quantity of food must be proportionate to his appetite. The patient should sleep 
well. After waking up in the morning, the first voided urine is collected in a wide 
mouthed glass container and is subjected to the analysis within one and half hours. 
 
Neerkkuri :  
“ YkR ¿odL¬ùVûP UQm ÖûW GgNùXu 
û\k§VÛ[ûY Vû\ÏÕ Øû\úV” 
£jR UÚjÕYôeL ÑÚdLm 
 
Urine has the following five characters, 
 1. Niram  - Colour of the Urine 
 2. Edai  - Specific gravity of the Urine 
 3. Manam - Smell of the Urine 
 4. Nurai - Frothy  nature of the Urine 
  5. Enjal  - Quantity (Increased or decreased amount) of Urine voided  
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Neerkkuri in Pandu noi :  
“ CVtûL ¿o ÑÚe¡àm CÕÜm NXlùTôÚs 
ùNVtûL VôVÚk§àm £ßjR ¿¬ÕÜm 
TôiÓ úSôn NmTYjûRj RÚª§p 
çiÓ \ôn úT§Ùm úNôoÜm ©\dÏúU” 
                                         úSôn SôPp úSôn ØRp SôPp §WhÓ 
Neikkuri :  
“ ¨\dÏ±d ÏûWjR ¨ÚUô] ¿¬t 
£\dL ùYiùQnúVôo £ßÕ° SÓ®Ój 
ùRuß\j §\kùRô­ úVLô RûUjR§ 
²u\§YûX úTôm ùS±®¯V±Üm 
ùNu\Õ ×LÛg ùNn§ûV ÙQúW” 
                                          úSôn SôPp úSôn ØRp SôPp 
The specimen collected for neikkuri is kept open in a glass dish being exposed 
well to the sunlight. Add one drop of gingelly oil without shaking. It should not be 
disturbed from its position and spreading of the oil drop should be noted. 
“ AWùY] ¿i¥]@úR YôRm” 
“ B¯úTôt TW®u A@úR ©jRm” 
“ ØjùRôjÕ ¨t¡u ùUô¯Y ùRu LTúU” 
Oil spreads like a snake   - Vatha neer 
Oil spreads like a ring    - Pitha neer 
Oil remaining and floating like a pearl - Kaba neer 
 
Neikkuri in pandu noi : 
“ ®ûWÜPu L§oúTôp ¿iÓ úYtßûUd ÏQeLs LiPôp 
ÏÚ§Rôu ùLhÓ SôNm Ïu± ÏQUùRuú]” 
If the oil spreads like a kathir (ray) it indicates pandu noi. 
 
ROLE OF MUKKUTRAM IN PANDU 
 
Vatham : 
Its mathirai alavu is 1 mathirai. (1 cc) 
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Location of vatham in the body : 
Vatham is located in the abanan, faeces, idakalai, spermatic cord, pelvic bone, 
skin, nerves, joints, hair and muscles. 
 
Vatham has ten forms : 
 
1. Piranan (Uyirkaal) : 
It resides in the heart and legs to nose and controls knowledge, mind and five objects of 
sense, useful for breathing. 
In pandu noi, it is affected when dysnoea is present. 
 
2. Abanan ( Keezh nokkukaal) : 
It is located in the lower abdomen and extremities. It is responsible for excretion of urine, 
stools, ejaculation of sperm and menstrual flow. 
In Pandu noi, it is affected when diarrhoea and oliguria are present. 
 
3. Viyanan (Paravukaal) : 
It resides mainly at the heart and responsible for movements of the body and sensation. 
In Pandu noi, it is affected when swelling of the body, pallor of eyes and lips are present. 
 
4. Samanan (Nadukkaal) : 
It is located in the stomach and helps for proper digestion. 
In pandu noi, it is affected if anorexia is present. 
 
5. Uthanan (Melnokkukaal) : 
It is located on the chest and responsible for vomiting, cough and sneezing. 
In pandu noi, it is affected when excessive thirst is present. 
 
6. Naagan : 
It is resides in the eyes and responsible for opening and closing of the eyelids and 
intelligence. 
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7. Koorman : 
It is located in the eyes. It causes winking of the eyelids, yawning and closure of mouth. It 
gives strength and helps to visualize things and causes lacrimal secretion. 
 
8. Kirukaran : 
It is located in the throat and responsible for salivation, nasal secretion and appetite. 
In Pandu, it is affected if anorexia is present. 
 
9. Devathathan : 
Its location is at eruvai and karuvai, It is responsible for laziness, sleep and anger. 
In pandu, it is affected if sluggishness and insomnia are present. 
 
10. Dhananjeyan : 
It resides in the nose and escapes on the third day after death by bursting the cranium. 
 
Pitham : 
Its mathirai alavu is ½   mathirai (½ cc) 
 
Five forms of pitham : 
 
1. Anala pitham : 
This gives appetite and helps for digestion. 
In Pandu, it is affected if loss of appetite is present. 
 
2. Ranjagam : 
It gives colour to the blood. 
In Pandu it is affected due to pallor of conjunctiva and skin. 
 
3. Saathagam : 
It controls the entire body functions responsible for the activities of the body  
In Pandu, it is affected due to inability to do the works properly and sluggishness. 
 
4. Alosagam : 
This gives brightness to the eyes. 
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5. Pirasagam : 
It gives complexion to the skin. 
In pandu, it is affected due to altered skin lusture. 
 
Kabam : 
Its mathirai alavu is ¼  mathirai. (¼cc) 
 
Location of Kabam in the body : 
Kabam is located in samanavayu, sperm, head, tongue, vulva, fat, bone marrow, 
blood, nose, chest, nerve, bone, brain, eyes and joints. 
 
Five forms of Kabam : 
1. Avalambagam : 
It controls  heart, lungs and other forms of kabam 
It is affected in Pandu, due to dyspnoea. 
 
2. Kilethagam : 
It makes the food wet and helps for digestion. 
In Pandu, it is affected due to anorexia. 
 
3. Pothagam :  
It is responsible for taste. 
In Pandu it is affected due to anorexia  
 
4. Tharpagam : 
It keeps the eyes cool. 
 
5. Santhigam : 
It is responsible for the lubrication and aids free movements of joints. 
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Paruvakaalam (Season ) : 
The whole year is constituted by six seasons, They are as follows. 
1. Kaar kaalam  - Avani and Puratasi  - Aug 16 to Oct 15 
2. Koothir kaalam  - Aippasi and Karthigai - Oct 16 to Dec 15 
3. Munpani kaalam  - Markazhi and Thai  - Dec 16 to Feb 15 
4. Pinpani kaalam  - Maasi and Panguni  - Feb 16 to Apr 15 
5. Ilavenil kaalam  - Chithirai and Vaigasi - Apr 16 to June15 
6. Mudhuvenil kaalam - Aani and Aadi  - June 16 toAug15 
In every season, changes will occur in the land, water, plants, animals and human 
beings, which will modify the physiology and make them susceptible to certain specific 
diseases which are common in that season.  
 
Physiologically the types of alterations of Mukkutram are, 
 Thannilai Valarchi Vetrunilai Valarchi Thannilai Adaithal 
Vatham Muthuvenil kaalam  Kaar kaalam Koothir kaalam 
Pitham Kaar kaalam Koothir kaalam Munpani kaalam 
Kabam Pin panai kaalam Ilavenil kaalam Muthuvenil kaalam 
 
Nilam : 
1. Kurinji  - Hill regions and surroundings 
2. Mullai  - Forest regions and surroundings 
3. Marutham  - Cultivating regions and surroundings 
4. Neithal  - Coastal regions and surroundings 
5. Palai  - Desert regions and surroundings 
People living in Kurinji, Mullai, Neithal and Palai may have in increased chance 
to acquire pandu noi. 
 
Udal Kattugal : 
Our body consists of seven udal kattugal. It gives strength to the body 
1. Saaram  -  It gives strength to the body and mind. 
2. Senneer -  It is responsible for knowledge, strength, boldness and healthy       
                            complexion. 
3. Oon  -   Gives structure and shape to the body and is responsible for  
     the  movement of the body. 
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4. Kozhuppu -  Lubricates the organs and proceeds on its own works, 
5. Enbu  -  Protects vital organs and is useful for movements. 
6. Moolai -  Present inside the bones and it gives strength and maintains  
      the  normal conditions of the bone. 
7. Venneer -  Responsible for the propagation of species. 
 
In Pandu , 
Saaram is affected which leads to sluggishness, dyspnoea and tiredness. 
Senneer is affected which leads to pallor of skin and conjuntiva. 
 
PROGNOSIS OF PANDU : 
Curable and Incurable Types : 
 SgÑ ùYÞl× úSôn ¾ÚYÕ A¬Õ. Ut\ ùYÞl× úSônLs RdL UÚkÕL[ôp 
G°§p ÏQUôÏùU²àm, AkúSônL°p Yôk§, L¯fNp, ÅdLm (FRp úSôn), 
¿oúYhûL, ®dLp, UÕúULm, Cû[l©ÚUp B¡V Ï±ÏQeL°úXúRàm Juß 
ApXÕ TX AkúSônL°p ÕûQ úSôVô¡j ÕuTeLû[ A§LUôL ®û[®d¡u 
G°§p ¾WôÕ. 
£jR UÚjÕYm. 
According to Sarabendrar  Vaidhya Muraigal : 
A§L Sô[ô] TôiÓ úWôLm £¡fûNdÏ YNlTPôÕ. ×§Rô]ôÛm EPp ÅdLj§p 
UgNs ¨\m LôQlThPôp ÏQm HtTPôÕ. UXf£dLúXô ApXÕ TfûN ¨\Uô] 
A§NôWúUô HtThPôp ANôj§Vm. 
TtLs, SLm, Li, CûYLs A§Lm ùYÞjRôÛm GpXôYtû\Ùm ùYi¦\UôL 
TôojRôÛm AkR úWôLm ANôj§VUôÏm. ANôj§V úWôLjûR Øt±Ûm ÏQl TÓjR 
Ø¥Vô®hPôÛm £±Õ Ï±ÏQeLû[ Ïû\jÕ BÙû[Ùm £XLôXm ¿¥dL ùNnVXôm. 
 
ûLLs, LôpLs, RûX ØRXô] CPeL°p ÅdLm HtThÓ Cû[jÕ Es[ TôiÓ 
úWô¡ûVÙm, BiÏ±, ùRôûP«ÓdÏ B¡V CPeL°p ÅdLm, A¥dL¥ UVdLm, 
A§NôWm ÑWm LiPôp ¾WôÕ. 
 
Asathiya Pandu : 
TôiÓ úWô¡dÏ ÅdLm, úNômTp, RôLm, AúWôNLm, Yôk§, ®dLp, CÚUp, úT§ 
Guàm CdÏQeLs EiPô¡ GkR YvÕûY TôojRôÛm UgNs ¨\ØiPô¡p 
ANôj§Vm.                     
ALj§Vo ûYj§Vl ©sû[j Rªr. 
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Kannusamiyam states that, 
“ùYl× ©¦VR²p ùYm úULjRôp YÚk§u 
Rl× ªûL ¿úW Rô²\e¡u  ùNl×m 
¡Wô¦«t Tôi¥p¡[o ¿oÑÚe¡t 
©WôQu ©¬ÙùU]l úTÑ” 
 
“ùNôpÛ ©jRj§t úNôûT úNôûTR²p YôÙ ùRôkRm 
YpXY§t TôiÓYu Tôi¥p  SpX 
Y«tßd LÓl× Y[o LÓl©t ºRm 
T«­t ùLÓ§ ùV]lT]” 
“TôiÓ ©WúULm TuYôR ãûX ÏuUm 
úYiPô NVgNu² ùYiúNôûT  ¿iP 
A§¿úW LôUôûX Vô]©¦ RmØ 
[§ NôWUô LôR±” 
According to Sadhaga Naadi, 
“Rô]ô] ©WúULm YôRãûX 
NôoYô] ¿¬¯Ü ÏuUúWôLm 
Uô]ô] NVúWôLg Nu²úRôPm 
VÓjR ®PeLôUôûX TôiÓ úNôûL 
Uôú] úLs LTúWôL Uk§W ®Vô§ 
UgNs úSôn ÏûXúSôÜ T«j§VúWôLm 
F]ôÏm YÚªPj§p V§NôWeLs 
EiPô¡pV Nôj§VôUô Øß§ Rôú]” 
 
NOI NEEKKAM (TREATMENT)  
The speciality of Siddha treatment emphasise not only for complete healings but 
also for the prevention and rejuvenation. This is said as follows,  
Kappu (Prevention) 
Neekkam ((Treatment) 
Niraivu (Restoration) 
Siddha system has stated that even during the time of conception, some defects 
creep into the fertilized embryo. These defects form the basis of the manifestation of 
certain constitutional disease later on during the existence of the individual. 
Diseases are produced by the unequillibrium of three thathus, which may be due 
to various causes like diet, life style pattern, mental and physical activities. 
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When treating for cure of the disease the following principles must be noted. 
“úSônSô¥ úSônØRp Sô¥VÕ R¦dÏm 
YônSô¥ YônlTf ùNVp” 
“Et\ô ][Üm ©¦V[Üm LôXØm 
Lt\ôu LÚ§f ùNVp” 
§ÚdÏ\s. 
So, it is essential to know the disease and the cause for the onset of disease, the 
nature of the patient, the severity of the illness, the season and the time of occurrence of 
the disease must be observed. 
 
Line of Treatment of Pandu : 
 
The aim is to normalize the vitiated mukkutram, vayus and the affected Raththa 
thathu.  
Before starting the actual treatment, the presence or absence of toxins in the body 
produced due to derangement of three thathus should be controlled. This is explained as 
follows. 
Nj§Vôp ©jRj RôÝm 
úT§Vôp YôRj RôÝm 
AgN]jRôp LTk RôÝm 
Usually for pitha diseases, emetics are to be given to restore the deranged  pitham. 
But there are some exceptions to this rule. For instance, in Pandu noi, since the patient is 
already weak and drowsy, the administration of emetic medicine is excluded from the line 
of treatment. 
1. To improve haemoglobin content of blood, iron preparations are used.  
2. Removal of the causative factors. 
3. Pathiyam ie, diet and other restrictioins to normalize the affected thathu and  
    to maintain a longer drug action. 
4. Intake of rich nutritious food is also a part of treatment. 
The author took TIRUDHARATCHATHA CHOORANAM(TC) as a trial drug for 
Pandu. 
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Diet : 
“UôßTô ¥pXô Ei¥ UßjÕi¦u 
FßTô ¥pûXÙ «odÏ. ” 
 §ÚdÏ\s  
“UÚkúR EQÜ, EQúY UÚkÕ”  
 §ÚêXo. 
 
Diet regimen for Pandu Noi : 
 Diet should be of strengthening the body and rejuvenating the blood. 
For Pandu noi, the following food items are recommended. 
 
Greens : 
           Karaisalai, Ponnanganni, Arukerai, Sirukeerai, Murungaikeerai, 
Manathakkalikeerai. 
 
Vegetables : 
 Kathiri pinju, Avarai pinju, Murungai pinju, Vazhai kachal may be given. 
 
Fruits : 
Dates, Orange, Grapes, Apple, Fig, Gooseberry, and Pomegranate. 
Easily digestible foods like porridge, mutton soup, bone soup must be given in 
acute stages of Pandu noi. Soup prepared from the liver or heart of goats may be given to 
rejuvenate the blood and strengthen the heart.  
After the normal appetite is restored properly, prepared meat of Kaadai, Kowthari 
and Udumbu can also be given. They tone up the deblitated system and also help in 
rejuvenation. 
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REVIEW OF LITERATURE 
MODERN ASPECTS 
 
The commonest nutritional deficiency disorder present throughout the world is 
iron deficiency but its prevalence is higher in the developing countries. This is due to 
poor hygienic status of people in these countries. 
 The blood is the most precious fluid in the body a fact that expressed in such 
common terms as “the life blood”. It is also considered as fluid of growth, fluid of health. 
Blood is one of the extracellular body fluids, which circulate in a closed system of blood 
vessels. It is an essential component of the internal environment. It’s physical and 
chemical constituents also remain constant with in physiological limits. The constant 
nature of the blood is one of the important haemostatic conditions of the body. 
 Blood contains iron in the form of Haemoglobin and also as cytochromes etc. Any 
form of iron deficiency cause anaemia. 
 
Blood 
Definition: 
 Blood is a complex fluid which circulates rapidly in closed system of blood 
vessels. 
Properties of Blood: 
1. Colour 
Blood is an opaque fluid and it is red in colour 
2. Volume 
The Volume of blood in a normal adult is 5 litres 
3. Reaction and PH 
Blood is slightly alkaline and its pH in normal condition is 7.4 
4. Specific gravity 
The specific gravity of total blood - 1.052 – 1.061 
The specific gravity of blood cells - 1.092 – 1.101 
The specific gravity of plasma       - 1.022 – 1.026 
5. Viscosity 
Blood is five times more viscous than water. It is mainly due to red blood cells 
and plasma proteins 
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Composition of Blood: 
 Blood consist of a solid portion and a fluid portion. The solid portion constitutes 
the blood cells namely RBC, WBC, and platelets and the fluid portion is plasma. The 
cells form 45% and the plasma forms 55% of the total volume of the blood. 
 
FUNCTIONS OF BLOOD 
 
1. Nutrient Function 
Nutritive substances like glucose, amino acids, lipids and vitamins derived from digested 
food are absorbed from gastro intestinal tract and carried by blood to different parts of the 
body for growth and production of energy. 
2. Respiratory Function 
Transport of respiratory gases is done by the blood. Blood conveys oxygen from the 
alveoli of lungs to the tissues for the oxidation of food and production of energy. The 
carbon-di-oxide formed in the tissues as a result of this process is carried to the lungs, 
where it is exhaled. 
3. Transport of hormones and enzymes 
The hormones and some of the enzymes are carried by blood to different parts of the body 
from the source of secretion. 
4. Excretory Function 
Waste products formed during various metabolic reactions in the tissues are removed by 
the blood and carried to the excretory organs like kidney, skin, liver etc 
5. Regulation of body temperature 
Because of high specific heat of blood, it is responsible for maintaining the 
thermoregulatory mechanism in the body. i.e. the balance between heat loss and heat gain 
in the body 
6. Regulation of acid – base balance 
The plasma proteins and haemoglobin act as buffers and help in the regulation of 
acid-base balance. 
7. Regulation of water balance 
Blood maintains the water content of the tissues and helps in the regulation of 
fluid in different compartments of the body 
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8. Regulation of osmotic pressure 
The plasma proteins play the major role in regulating the osmotic pressure of 
tissue fluids 
9. Defensive Function 
Blood has WBCs , Gamma globulins which have phagocytic action. They also 
transport protective subtances  such has anti-bodies, anti-toxins and lysins. 
10. Storage Function 
Water and some important substances like protein, glucose, sodium and potassium 
are constantly required by the tissue. Blood serves as a readymade source for these 
substances and these substances are taken from the blood during conditions like 
starvation, fluid loss, and electrolyte loss. 
 
The Red Blood cells or Erythrocytes: 
The erythrocytes of most of the higher animals including man are circular, non-
nucleated, biconcave discs. 
 Diameter : 7.2 µ (6.9 – 7.4 µ) 
 Thickness : At the periphery it is thicker with 2.2 µ and 
    at the it center is thinner with 1 µ 
 Because of this, the outer edge appears as a rim around a central depression, and 
when seen edge-wise, it has approximate appearance of dumb-bell.  
 Surface Area : 120 square µ 
 Volume : 85 – 90 Cubic µ 
 
Properties of RBC 
1. Rouleaux formation 
 When blood is taken out, the red blood cells pile up one above another like the 
pile of coins. This property of red blood cell is called rouleaux formation. 
2. Specific Gravity 
 The specific gravity of red blood cell is 1.092 to 1.101. 
3. Packed Cell volume 
 When the blood is collected in a centrifuge tube along with proper anticoagulant 
and centrifuged for a period of 30 minutes at a speed of 3000 rpm the red blood cells 
settle at the bottom of the tube leaving the clear plasma at the top. The red blood cells 
form 45% of the total blood. This is called the packed cell volume or hematocrit.  
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4. Suspension Stability 
During circulation the red blood cells remain suspended uniformly in the blood. This 
property of the red blood cells is called the suspension stability 
 
Erythropoiesis 
 Erythropoiesis is the process by which the origin, development and maturation of 
erythrocytes occur. 
 In the bone marrow, there are cells called uncommitted pluripotent hemopoietic 
stem cells because these cells are not designed to form a particular type of blood cell. 
When these cells are designed to form a particular type, the stem cells are called 
committed pluripotent hemopoietic stem cells. 
 The different committed stem cells will produce colonies of specific types of 
blood cells. Then a committed stem cell that produces colony forming unit blast (CFU – 
B) and then erythrocytes are produced from these CFU – B and are called colony forming 
unit – erythrocytes (CFU-E). 
 Growth and reproduction of the different stem cells are controlled by multiple 
proteins called growth inducers. Another set of proteins are called differentiation inducers 
whose function is differentiation of the cells. 
 
Sites of Erythropoiesis 
1. In the early few weeks of embryonic life  - yolk sac 
2. During the middle trimester of gestation  - Liver, Spleen, lymphoid organ 
3. Later part of gestation and after birth       - Red bone marrow and liver 
4. Up to the age of 5                                   - Red bone marrow of all the   bones 
5. After the age of 5 to Adult                       - Red bone marrow of long bones and flat bones    
 
Stages of Erythropoiesis 
 
Stage I – Pro erythroblast (Megaloblast) 
  This early cell is large (15-20) µ. The cytoplasm is basophilic staining with 
a deep violet blue and there is a pale-staining crescent near the nucleus and the cell 
contains no haemoglobin. The nucleus is about 12µ and occupies about three quarters of 
the cell volume and the chromatin forms a fine stippled reticulum. 
Stage II – Early Normoblast (Early erythroblast) 
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  This cell is smaller than pro erythroblast diameter 15µ. It shows active 
mitosis. The nucleoli have disappeared. Condensation of chromatin network occurs. The 
cytoplasm is basophilic. So this cell is also called basophilic erythroblast. 
 
Stage III – Intermediate Normoblast (Late erythroblast) 
 This cell is smaller (10-15) µ and shows active mitosis. Nucleus is still present. 
Chromatin network shows further condensation. Haemoglobin begins to appear and its 
eosinophilic staining give the cytoplasm a polychromatic appearance. 
 
Stage IV – Late Normoblast (Normoblast) 
 Mitosis has now ceased and the diameter of the cell is 8 – 10 µ. The nucleus 
becomes very smaller and the condensed chromatin assumes a “cart wheel” appearance 
or ink spot and finally becomes deeply stained in a uniform manner. Quantity of 
haemoglobin increases. Cytoplasm becomes almost acidophilic. So the cell is called 
Orthochromic erythroblast. In this cell, the nucleus disintegrates and disappears. The 
process is called pyknosis. 
 
Stage V – Reticulocyte 
 It is slightly larger than matured red blood cells. Cytoplasm contains reticular 
network. It is basophilic in nature. During this stage, the cells enter the blood through the 
capillary membrane by means of a process called diapedesis. 
 
Matured Erythrocyte 
 Reticular network disappears. Matured red blood cell is biconcave; smaller in size; 
diameter of 7.2 microns. It is with haemoglobin and without nucleus. 
 It takes 5 days for the development of reticulocyte from proerythroblast. The 
reticulocyte take two more days to become matured red blood cells. 
 
Changes during Erythropoiesis 
 Four important stages occurring are, 
1. Reduction in size of the cell 
2. Disappearance of nucleoli and nucleus 
3. Appearance of Haemoglobin 
4. Change in the staining properties of the cytoplasm 
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Regulation of Erythropoiesis 
1. Tissue oxygenation is the basic regulator of red blood cell production. Any condition 
that causes the quantity of oxygen transported to the tissues to decrease (Hypoxia) 
ordinarily increases the rate of red blood cell production. Hypoxia occurs in conditions 
like very high altitudes, anaemia, prolonged cardiac failure, cyanotic heart disease and 
lung disease. 
2. Erythropoietin is a circulatory hormone, formed mainly in kidneys, increase mainly 
during hypoxia. It stimulates the production of proerythroblast from hempoietic cells in 
the bone marrow. 
3. Epinephrine, norepinephrine and several of the prostaglandins stimulate 
erythropoietic production. 
 
Life Span and fate of Red Blood Cells 
 Average life span of red blood cell is about 120 days. The senile red blood cells 
are destroyed in reticulo endothelial system. 
 When the cells become older, the cell membrane become more and more fragile. 
The diameter of the capillaries is less or equal to that of red blood cells. The younger red 
blood cells can pass through the capillaries easily; however the older cells become fragile. 
So these cells are destroyed while trying to squeeze through the capillaries. The 
destruction occurs mostly in the capillaries of spleen because the splenic capillaries have 
a thin lumen. So the spleen is usually called ‘grave yard’ of red blood cells. Daily 10% of 
red blood cells, which are senile, get destroyed in normal young healthy adults.  
 
Normal values of Erythrocytes 
 Infants  -   4 – 4.5 million/cu.mm 
 2 – 6 years -   4.5 million/cu.mm 
 6-14 years -   4.5 – 4.8 million/cu.mm 
 
Haemoglobin 
 Haemoglobin is a conjugated protein consisting of iron containing pigment 
protein called Haem (4%) and a protein of the histone class called globin (96%). Haem is 
an iron containing porphyrin known as iron protoporphyrin IX (metallo porphyrin). 
Therefore haemoglobin is an iron + porphyrin + globin compound. 
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 Four haem molecules are attached to the globin molecules to form one molecule 
of haemoglobin. The molecular weight of haemoglobin is 68,000. This high molecular 
weight and consequently great size of the molecules are the cause of the colloidal nature 
when they are dispersed in water. It is a chromoprotein, forming 95% of dry weight of red 
blood cell and 30 to 34 % of wet weight. 
 
Varieties of haemoglobin 
 Haemoglobin is of two types namely. 
1. Adult haemoglobin – HbA 
2. Fetal haemoglobin – HbF 
There are some structural differences between these two types of haemoglobin. In adult 
haemoglobin the globin contains 2 alpha chains and 2 beta chains. In fetal haemoglobin 
there are two alpha chains and two gamma chains instead of beta chains.  
 
Formation of haemoglobin: 
1. 2 Succinyl co-A + 2 glycine     à  4 Pyrrole 
2. 4 Pyrrole        à Protoporphyrin IX 
3. Protoporphyrin IX Fe ++         à Haeme 
4. Haeme + polypeptide       à Haemoglobin chain (Alpha or Beta) 
5. 2 Alpha chains + 2 Beta chains    à Haemoglobin A 
 
Properties of haemoglobin: 
1. Buffering Capacity: 
Haemoglobin is an effective buffer. Its isoelectric point is 6.8. The buffering 
capacity of haemoglobin is due to the presence of large number of histidine residues in 
the globin fraction. It is estimated that a molecule of haemoglobin has 35 histidine 
residues 
2. Transport of oxygen: 
The physiological importance of haemoglobin is due to its capacity to combine 
reversibly with oxygen. It combines with haemoglobin to form oxyhaemoglobin readily, 
at high pressure as existing in the lungs. Oxyhaemoglobin readily dissociates, at low 
partial pressure as prevailing in the tissues. This property of haemoglobin provides an 
effective and excellent system for the transport of oxygen from the atmosphere (lungs) to 
the cells of the body. 
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3. Haem-Haem interaction: 
    The haem groups in haemoglobin combine with oxygen in such a way that each haem 
group combine with one molecule of oxygen. 
4. Combination with Carbon monoxide: 
     Haemoglobin combines with carbon monoxide to form carboxy haemoglobin with an 
affinity, two hundred times more than with oxygen. 
5. Formation of carbamino compound: 
     A small amount of CO2 carried in the blood is in combination with the free amino 
acids of the proteins of haemoglobin to form carbamino compounds 
(Hb.NH2 + CO2  àHb.NHCOOH)  
6. Oxidation- Reduction properties of haemoglobin: 
Under normal conditions, iron exists in ferrous form in the haemoglobin. It can be 
converted to ferric form by oxidation with ferricyanide and this result in the formation of 
Methemoglobin. 
7. Action of weak acids and alkalies: 
     Weak acids and alkalies act on haemoglobin by separating the haem from globin. In 
the presence of oxygen, haem gets oxidized to haematin in which iron is in the ferric 
form. Haematin can combine with the chloride ion to form haematin chloride, which is 
also known as haemin. 
8. With strong acids 
A more vigorous change takes place with strong acids. In addition to the separation of 
globin from haemoglobin, the iron from the haem is removed, resulting in the formation 
of an iron free derivative. 
Metabolism of Haemoglobin 
I. Synthesis of haemoglobin 
II. Catabolism of haemoglobin 
III. Conversion of haemoglobin to bile pigments 
 
I. Synthesis of haemoglobin 
In adults synthesis of haemoglobin takes place in the red bone marrow from 3 sources 
namely, protoporphyrin, Iron and globin. Certain co-factors are required to facilitate the 
synthesis. 
1. Vitamin B12 (extrinsic factor)  2. Intrinsic factor 
3. Folic acid group of vitamins  4. Copper 
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Synthesis of haemoglobin and maturation of the erythrocytes proceeds 
simultaneously. The immature erythrocyte contains free porphyrin. As the cells mature 
the porphyrin content decrease and is replaced by haemoglobin. Thus the circulating red 
blood cells, which are rich in haemoglobin, contain only traces of porphyrin. 
 
II. Catabolism of haemoglobin 
Erythrocytes at the end of their life span of 120 days are broken down. 
Simultaneously the haemoglobin is degraded. Daily about 8 gms of haemoglobin are 
broken down in the body and this corresponds to the formation of about 300 mg of bile 
pigments per day. The normal sites of haemoglobin degradation are mainly the 
reticuloendothelial cells of the spleen, bone marrow and liver. The globin which is the 
protein portion may be reutilized as such or may break down further into its constituent 
amino acids and enter to be amino acid “pool” for reutilization. The haem portion breaks 
down resulting in the formation of bile pigments. 
 
Normal values of haemoglobin of different age groups 
 Mean(gm/dl) Range(gm/dl) 
Cord blood 17.1 13.7 – 20.5 
7 days 18.8 14.6 – 23.0 
20 days 15.9 11.3 – 20.5 
45 days 12.7 9.5 – 15.9 
75 days 11.4 9.6 – 13.2 
120 days 11.9 9.9 – 13.9 
1 year 12.2 10 – 13.0 
5 year 12.5 12 - 13 
10 year 13.5 13 - 14 
Older 15 14 - 16 
 
Packed cell volume and blood indices 
Packed cell volume (PCV) is the haematocrit value expressed as the percentage of 
cellular elements with that of whole blood.  
 
45 
 
Significance of determining PCV 
Determination of PCV helps in 
1. Diagnosis and treatment of anaemia 
2. Diagnosis and treatment of polycythemia 
3. Determination of extent of dehydration and recovery from dehydration after treatment 
4. Decision of blood transfusion 
 
Blood Indices 
Blood indices are specifically meant for erythrocytes. The number, shape, volume 
and colour of the red blood cells indicate the quality of blood. So these features are 
named as blood indices. 
 
IMPORTANCE OF BLOOD INDICES 
Blood indices have got diagnostic value in determining the type of anaemia 
 
Different Blood Indices 
Following are the various blood indices 
1. Mean corpuscular Volume (MCV) 
2. Mean corpuscular haemoglobin (MCH) 
3. Mean corpuscular haemoglobin concentration (MCHC) 
4. Colour Index (CI) 
 
1. Mean corpuscular Volume (MCV) 
Mean corpuscular Volume is the average volume of single red blood cells and it is 
expressed in cubic microns (cu.µ). 
PCV in 1000 ml or 100 ml x 10
RBC count in millions / cu.mm
MCV =
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2. Mean corpuscular haemoglobin (MCH) 
Mean corpuscular haemoglobin is the quantity or amount of haemoglobin present 
in one red blood cell. It is expressed in micro gram or pico gram (pg). 
 
3. Mean corpuscular haemoglobin concentration (MCHC) 
This is the concentration of haemoglobin in one red blood cell. It is the amount of 
haemoglobin expressed in relation to volume of one red blood cell. So the unit of 
expression is percentage. 
Haemoglobin in grams per 1000 ml of blood x 10
PCV in 100 ml of blood
MCHC  =
 
4.Colour Index (CI) 
This is the ratio between the percentage of the haemoglobin and the percentage of 
red blood cells in the blood. 
All the above mentioned blood indices are reduced in iron deficiency anaemia 
 
Normal values: 
 
Packed Cell Volume (Haematocrit value) – (P.C.V) 
1 – 13 days   - 54 ±10.0% 
14 – 60 days   - 42.0 ±7.0% 
3 months – 10 years  - 36.0 ±5.0% 
11 – 15 years   - 39.0 ±5.0% 
 
Mean Corpuscular Volume (M.C.V) 
1 – 13 days   -  106 – 98 fl 
14 – 60 days   -  90 fl 
3 months – 10 years  -  80 fl 
11 – 15 years   -  82 fl 
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Mean Corpuscular Haemoglobin (M.C.H) 
1 – 13 days   -  38 – 33 picograms 
14 – 60 days   -  30 picograms 
3 months – 10 years  -  27 picograms 
11 – 15 years   -  28 picograms 
 
Mean Corpuscular Haemoglobin Concentration (M.C.H.C) 
1 – 13 days   -  36 – 34 g/dl 
14 – 60 days   -  33 g/dl 
3 months – 10 years  -  34 g/dl 
11 – 15 years   -  34 g/dl 
 
Mean corpuscular diameter (M.C.D) 
1 – 13 days   -  8.6 µm 
14 – 60 days   -  8.1 µm 
3 months – 10 years  -  7.7 µm 
11 – 15 years   -  7.6 µm 
 
Reticulocytes 
Cord blood   -  5.0% 
2 weeks   -  1.0% 
3 months   -  1.0% 
6 months – 6 years  -  1.0% 
7 – 12 years   -  1.0% 
Adult    -  1.6% 
 
IRON 
 
Iron is an essential constituent of haemoglobin, myoglobin, cytochromes and other 
components of respiratory enzymes like cytochrome oxidase, catalase and peroxidase. 
The main functions of iron are, 
1. Transport of oxygen to the tissues 
2. Iron is necessary for electron transport chain, oxidative phosphorylation 
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3. Peroxidase, lysosomal enzyme, is required for phagocytosis and killing of bacteria by   
neutrophils 
4. Iron is associated with effective immune competence of the body. 
  
Daily Iron Requirements in different age groups: 
Pregnant and lactating females -  40 mg/day 
Females 11 years to 30 years   -  18 mg/day 
Adults males     -  10 mg/day 
Males 11 years to 17 years   -  12 mg/day 
Upto 10 years (M/F)    -  10 mg/day 
Full term infants    -  1 mg/kg/day from 4 months of age 
LBW babies     -  2 mg/kg/day from 2 months of age 
Babies 1000 to 1500 grams   -  3 mg/kg/day from 2 months of age 
Less than 1000 grams    -  4 mg/kg/day from 2 months of age 
 
Iron sources 
 Rich Sources 
· Muscle meat (Red more than white) 
· Organ meat (Liver, heart, kidney) 
· Beef liver 
Red meat not only supplies a good amount of iron it also increases absorption of 
iron from other food sources 
Good Sources 
· Greens 
· Leafy vegetables 
· Nuts 
· Cereals 
· Wheat germs 
· Fish 
· Shellfish 
· Poultry 
· Egg 
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· Iron fortified cereals and foods 
· Apples and dry fruits 
· Jaggery 
· Yeast 
· Molasses 
· Oysters 
Poor Sources 
· Wheat and Polished rice 
 
Distribution of iron in the body 
Total quantity of iron in the body averages 4 - 5 gm of total body weight. 
Iron is distributed in the body as follows. 
1) Haemoglobin – present in red cells contain most of the body iron (65%) 
2) Myoglobin – comprises a small amount of iron in the muscles (4%) 
3) Haem and non-haem enzymes – eg cytochrome catalase, peroxidase, succinic 
dehydrogenase and flavoproteins constitute a fraction of total body iron (0.5%) 
4) Transferrin bound iron – circulates in the plasma and constitutes another fraction of 
total body iron (0.5%).  
 All these forms of iron are in functional form 
5) Ferritin and haemosiderin – are the storage form of excess iron (30%). They are stored 
in the mononuclear phagocytic cells of the spleen, liver and bone marrow and in 
parenchymal cells of the liver 
Iron Metabolism: 
The iron required for haemoglobin synthesis is derived from two primary sources – 
ingestion of food containing iron and recycling of iron from senescent red cells. 
Absorption 
Iron is mostly found in food in ferric form. In the acidic medium provided by 
gastric HCl, the Fe3+   is released from food. Ascorbic acid (Vitamin C) and cysteine 
convert ferric form to ferrous form. This ferrous form is soluble and readily absorbable. 
Absorption of iron takes place from almost all part of the small intestine mainly from 
duodenum and proximal jejunum. Iron from diet containing haem is better absorbed than 
non haem iron. 
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Factors affecting iron Absorption 
1) Acidity, ascorbic acid and cysteine enhances iron absorption 
2) In Iron deficiency anaemia iron absorption is increased to 2 to 10 times that of normal 
3) Small peptides and amino acids favour iron absorption 
4) Phytate and oxalate (found in leafy vegetables) interfere with iron absorption. 
5) Food additives (EDTA) and antacids reduce iron absorption 
6) A diet with high phosphate which are found in soft drinks, beer, ice cream, candy bar          
decreases iron absorption 
7) Smoking and alcohol interferes with iron absorption 
8) Impaired absorption of iron is observed in malabsorption syndrome such as 
steatorrhea 
9) In patients with partial or total surgical removal of stomach, iron absorption is 
severely impaired 
 
Iron in the mucosal cells: 
The iron (Fe2+) entering the mucosal cell by absorption is oxidized to ferric form 
(Fe3+) by the enzyme ferroxidase. Fe3+   then combines with apoferritin to form ferritin 
which is the temporary storage form of iron. Form the mucosal cells, iron may enter the 
blood stream (which mainly depends on the body needs) or lost when the cells are 
desquamated. 
 
Transport of iron in the plasma: 
The iron liberated from the ferritin of mucosal cells enters the plasma in ferrous 
state. Here, it is oxidized to ferric form by a copper containing protein, ceruloplasmin 
which possesses ferroxidase activity. Another cuproprotein ferroxidase II also helps for 
the conversion of Fe2+ to Fe3+. 
Ferric iron then binds with a specific iron binding protein, namely transferrin or 
siderophilin. The plasma transferrin can bind with 400 mg of iron/dl plasma. This is 
known as total iron binding capacity (TIBC) of plasma.  
 
Storage of Iron: 
Storage of excessive iron in the blood is deposited in all cells especially in the 
liver hepatocytes. The hepatic cells contain large amounts of a protein called apoferritin, 
which is capable of combining reversibly with iron. Therefore when iron is available in 
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the body fluids in extra quantities, it combines with apoferritin to form ferritin and stored. 
When iron is in the low level, the ferritin releases the iron. Thus, apoferritin – ferritin 
system of liver acts as blood iron buffer as well as iron storage medium. Hemosiderin is 
another iron storage protein and this is insoluble form.  
 
Excretion 
The body is unable to regulate its iron content by excretion alone. The amount of 
iron lost per day is 0.5 – 1.0 mg which is independent of iron intake. This loss is nearly 
twice more (i.e. 1 – 2 mg per day) in menstruating women. Iron is lost from the body as a 
result of desquamation of epithelial cells from the gastro intestinal tract, sweat, and loss 
via hair and nail. Iron excreted in the faeces mainly consists of unabsorbed iron and 
desquamated mucosal cells.  
 
Regulation of total body iron 
Absorption and excretion of iron are maintained almost equally under normal 
physiological conditions. When the iron storage is saturated in the body, it automatically 
reduces the further absorption of iron from the gastrointestinal tract by feedback 
mechanism. The factors, which reduce absorption of iron are, 
 
1. Stoppage of apotransferrin formation in the liver, so that the iron could not be absorbed 
from the intestine 
2. Reduction in the release of iron from the transferrin so that transferrin is completely 
saturated with iron and further absorption is prevented. This type of regulation is known 
as feedback mechanism 
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ANAEMIA 
 
DEFINITION: 
Anaemia is defined as a reduction of the red blood cell volume or haemoglobin 
concentration below the range of values occurring in healthy persons. 
WHO criteria for diagnosis of Anaemia 
Children 6 months - 6 years  Less than 11 
Children 6 years -14 years  Less than 12 
 
Grading of Anaemia:           
 WHO grades anaemia according to haemoglobin level as follows, 
Hb between 10 gm and cut off point for age  -  Mild 
Hb between 7 to 10 gm    -  Moderate 
Hb under 7 gm     -  Severe 
Hb under 5 gm     -  Very Severe. 
 
CLASSIFICATION 
 
A. Based on Production/destruction of RBC 
A useful classification of the anaemia of childhood divides them into 2 broad 
groups. 
I. Decreased or ineffective production of red blood cells or haemoglobin  
II. Increased destruction or loss of red blood cells. 
 
Anaemia resulting primarily from inadequate production. 
 
I. Marrow failure 
1. Aplastic anaemia 
  Congenital, acquired 
2. Decreased number of red blood cell precursors in the marrow  
  Congenital, acquired 
3. Marrow replacement 
  Malignancies, osteopetrosis 
  Storage disorders 
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II. Deficiency of Specific Factors 
1. Megaloblastic anaemia 
Folic acid deficiency or malabsorption 
  B12 deficiency or malabsorption 
2. Microcytic anaemia 
 
 Iron deficiency 
 Copper deficiency 
 Lead poisoning 
 
III. Impaired Erythropoietin Production 
1. Chronic renal disease  
2. Hypothyroidism, Hypopituitarism 
3. Chronic inflammation, infection 
4. Malignancy 
5. Protein malnutrition 
 
Anaemia resulting primarily from rapid destruction. 
 
I. Blood Loss 
Acute haemorrhage 
Chronic haemorrhage 
 
II. Haemolytic Anaemia 
a. Intrinsic Defects 
Intrinsic abnormalities 
Membrane Defects (Membranopathy) 
Hereditary spherocytosis, elliptocytosis 
Enzyme Defects (Enzymopathy) 
Enzyme of glycolytic pathway 
Enzyme of the pentose phosphate pathway 
         Defects in synthesis of haemoglobin (Haemoglobinopathy) 
Hb S, C, D, E 
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b. Extrinsic abnormalities 
i. Immunologic disorders 
 Rh iso immunization  
 A (or) B iso immunization 
 Other minor Blood group incompatibilities 
ii. Active antibody formation 
 
B. Morphological classification 
Based on the red cell size, haemoglobin content and red cell indices anaemia are 
classified as follows  
 
1. Microcytic Hypochromic anaemia Iron deficiency,  
 Thalassemia 
 haemoglobinopathies  
 haemolytic anaemia. 
2. Normocytic normochromic anaemia Aplastic anaemia 
3. Macrocytic normochromic anaemia Folate and vitamin B12 deficiency 
hypothyroidism 
4. Macrocytic hypochromic anaemia Combined deficiency of iron and folate or 
Vitamin B12 
 
Microcytic anaemia: 
The size of red cells is smaller than normal and colour index less than one. The 
mean corpuscular volume is less than 78 cubic microns 
 
Causes of Microcytic anaemia: 
a) Inadequate intake of iron, defective absorption of iron, idiopathic hypochromic 
anaemia, starvation, dietary deficiency, anaemia of milk fed children. 
b) Excessive need of iron during growth, pregnancy 
c) Chronic haemorrhages 
d) Inadequate utilization of haematinics – myxoedema, chronic sepsis, chronic renal 
diseases. 
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Macrocytic anaemia: 
The red cells are bigger than normal and the colour index is above one. The mean 
corpuscular volume is more than 94 cubic microns. 
 
Causes of Macrocytic anaemia: 
a. Deficiency of the extrinsic factors, nutritional anaemias, pellagra. 
b. Absence of intrinsic factor, total gastrectomy 
c. Cirrhosis of liver 
d. Megaloblastic anaemia, hypoblastic anaemia. 
 
Normocytic Anaemia: 
The size of the red cells is more or less than the normal size. The colour index is 
less than the normal range and the mean corpuscular volume is 78 to 94 cubic microns. 
 
Causes of Normocytic anaemia: 
a. Acute hemorrhage 
b. Haemolytic anaemias 
c. Blood destruction by metals, protozoa, haemolysis 
d. Leukemia, Hodgkin’s disease, drug poisoning 
 
B. Based on Etiopathogenesis: 
1. Nutritional Anaemias PEM, Iron, Folic acid, Vitamin B12, Vitamin C, 
pyridoxine, or thyroxine deficiency. 
 
2. Haemolytic Anaemias 
Congenital    Thalassemia 
     Sickle cell anaemia 
     Hereditary spherocytosis 
     G-6-PD deficiency 
Acquired    Malaria   
Kala azar  
Rh or ABO incompatibility 
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3. Haemorrhagic 
Acute Trauma 
 Epistaxis  
 Haemorrhagic disease of   newborn 
 Scurvy 
Chronic Hookworm 
 Chronic dysentery 
 Oesophageal varices 
4. Bone Marrow Depression 
Primary Hypoplasia or Aplasia 
 Fanconi’s Anaemia 
Secondary Infections 
 Irradiation 
5. Infections 
Acute Fulminating osteomyelitis 
 Septicaemia 
Chronic Tuberculosis 
 Rheumatic fever 
 Sub acute bacterial endocarditis 
 Wound infections 
 Congenital syphilis 
6. Other Miscellaneous Conditions  
 Chronic amoebic dysentery 
 Repeated bouts of diarrhea 
 
57 
 
CLINICAL FEATURES OF ANAEMIA 
 
The haemoglobin level at which symptoms and signs of anaemia develops 
depends upon 4 main factors. 
 
1. The Speed of onset of anaemia: 
Rapidly progressive anaemia causes more symptoms than anaemia of slow onset, 
as there is less time for physiological adaptation. 
 
2. The Severity of Anaemia: 
Mild anaemia produces no symptoms or sign, but a rapidly developing severe 
anaemia (haemoglobin below 6 gm) may produce significant clinical features. 
 
3. The age of the patient: 
The young patient due to good cardiovascular compensation tolerate anaemia 
quite well as compared to the elderly 
 
4. The haemoglobin dissociation: 
In anaemia, the affinity of haemoglobin for oxygen is depressed. As a result oxy 
haemoglobin is dissociated more readily to release free oxygen for cellular use. 
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PATHOLOGICAL RED BLOOD CELLS IN ANAEMIA: 
 
In anaemia, many kinds of abnormal red cells including nucleated forms are seen 
in the circulation. These abnormal cells are, 
 
I. Anisocytosis (Variation in size of RBC) 
a. Macrocytosis: 
The size of the cell is 9 to 12 microns. This occurs in pernicious anaemia, 
plumbism, acute anaemia due to severe haemorrhage and erythroblastosis foetalis 
b.Microcytosis: 
The size is less than 6 microns. This occurs in Iron deficiency anaemia, chlorosis, 
chronic bleeding, polycythaemia and anaemias secondary to infections. 
c. Normocytosis: 
The red cells are in normal size, found mainly in post haemorrhagic anaemias. 
II. Poikilocytosis (Variation in shape of RBC) 
a. Ovalocytosis: 
The oval shaped red cells occur in some human families. Such a condition does not cause 
ill-health, but a minority may manifest haemolytic phenomena. 
b. Spherocytosis: 
Spherocytosis may be seen in congenital haemolytic anaemia and in certain other acute 
haemolytic anaemias. The red cells are very fragile. 
c. Sickle cells: 
In arterial blood, the red blood cells are normal in shape, but in venous blood some cells 
assume the shape of sickle. 
III. Polychromatophilia (Irregularity in staining) 
This indicates an increase in immature red cells in circulation and occurs in the 
following forms 
a) Normoblasts: 
Nucleated red cell indicates over activity of bone marrow, commonly seen in severe 
anaemia. 
b) Punctate Basophilia (Basophilic stippling): 
It occurs in lead poisoning and severe anaemia,  and chronic malaria. 
c) Reticulocytes:  
Occurs in acute bleeding and in pernicious anaemia. 
59 
 
IRON DEFICIENCY ANAEMIA (IDA) 
 
Iron deficiency is the most common and widespread nutritional disorder in the 
world. The numbers are staggering: 2 billion people – over 30% of the world’s population 
– are anaemic, many due to iron deficiency. Malaria, HIV/AIDS, hookworm infestation, 
schistosomiasis, and other infections such as tuberculosis are particularly important 
factors contributing to the high prevalence of anaemia in some areas. 
 Iron deficiency and anaemia reduce the work capacity of individuals and entire 
populations, bringing serious economic consequences and obstacles to national 
development.  
 
Iron Requirements during childhood 
Understanding of iron requirements, intakes and bioavailability is essential to 
explain the vulnerability of some individuals to develop iron deficiency anaemia.  
 
The iron released from the senescent, red cells during the first 8-12 weeks of life   
(a period of quiescent erythropoiesis) is stored in the body and helps to maintain 
erythropoiesis upto 4-6 months in a normal term infant and upto 2-3 months in low birth 
weight infant. Normal infants at birth have about 75 mg of iron per kg body weight, two 
thirds of which is present in red blood cells. Infant and children should continue to absorb 
0.8 to 1.0 mg of iron daily to reach the adult body stores of 4-5 gms. 
 
Normal body losses of iron are about 20µg/kg/day and most of these losses occur 
by the shedding of cells from intestinal mucosa. These losses are small and are relatively 
constant but may increase many folds in the presence of diarrhoea, dysentery, and 
parasitic infections. 
 
Certain factors protect infants from becoming iron deficient in first few months of 
life. These include, 
1. Preferential delivery of iron to the fetus during the pregnancy particularly during last 
three months of gestation. 
2. Placental transform to the newborn immediately after birth when the cord is allowed to 
pulsate before being clamped. 
3. Exclusive breast feeding for first four to six months of life, due to better bioavailability 
of iron from the breast milk. 
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STRUCTURES OF THE RED CORPUSCLES IN IDA: 
In iron deficiency anaemia, the red blood corpuscles are decreased or normal in 
the number and haemoglobin content of the red blood corpuscles is reduced. In the blood 
smear, the red cells appear pale with a large central pale area and many of the red blood 
cells appear to be smaller than the normal. This type of anemia is called “Hypochromic 
and Microcytic anemia”.  
 
 Etiology: 
The etiology varies with the age, sex, and country of residence of the patient. 
 
Etiological factors in iron deficiency Anaemia: 
 
1. Increased physiological requirements 
   Rapid growth: Infants, preadolescence 
   Menstruation 
   Pregnancy  
2. Decreased iron stores 
   Preterms 
   Small for dates 
   Twins 
3. Decreased iron assimilation 
   Iron poor diet 
   Iron malabsorption 
   Sprue, non tropical sprue 
   Pica 
   GI surgery 
   Chronic diarrhoea 
   Delayed weaning 
   Malnutrition 
4. Blood Loss 
   Gastro intestinal bleeding 
   Milk induced enteropathy 
   Peptic ulcer disease 
   Inflammatory bowel disease 
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   Meckel’s diverticulum 
   Drugs – Salicylates 
   Hook worm infestation 
   Fetal Maternal transfusion 
   Haemoglobinuria – prosthetic heart valve 
   Iatrogenic 
   Intense exercise 
   Bleeding diasthesis 
   Repeated venous sampling 
5. Increased demands 
   Prematurity 
   Low birth weight 
   Recovery from PEM 
   Adolescence  
 
Growth 
Iron deficiency anaemia is more in children between ages of 6 months and 2 years 
and from 11 to 16 years due  to spurts of growth during these periods. 
Menstruation 
Iron deficiency in post pubescent girls is most commonly caused by the loss of 
more iron through menstruation. 
Pregnancy 
During pregnancy, anaemia is almost universal. 
 
IRON POOR DIET 
· Dietary inadequacy is present in more than 80 percent of cases especially in the 
poorer groups. This is still encountered in privileged societies under the following 
circumstances 
· Infants are also at high risk because the diet predominantly milk contains very small 
amounts of iron. Human milk provides only about 0.3 mg/ litre of iron 
· Premature babies have only lesser amount of storage iron in the liver as well as body 
· Children especially during the early years of life have a need for dietary iron to 
accommodate growth and expansion of the blood volume. 
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 IRON MALABSORPTION: 
· Iron malabsorbtion is an unusual cause of iron deficiency where malnutrition is 
rampant however both histologic and functional abnormalities of the intestine are 
common. Defective iron absorption is 
· caused by non-tropical sprue. 
· Partial or total gastrectomy impairs iron absorption caused by reduction in gastric 
acidity and 
· acceleration of the food through the upper portion of the small bowel. The absorption 
of both haem  
· iron and non-haem is defective. 
· Pica or the habitual ingestion of non-food substances is common in children and 
pregnant women. It  
· markedly inhibit iron absorption. 
· Pancreatic enzymes may contribute to the high incidence of iron deficiency in patients 
with cystic 
· fibrosis. 
 
GASTRO INTESTINAL BLEEDING: 
· In adult men and postmenopausal women, occult bleeding from the gastrointestinal 
tract is the most common cause of iron deficiency. 
· Gastrointestinal bleeding also is prevalent among iron deficient infants and children.  
· Characteristically gastro intestinal bleeding is occult and unsuspected 
· Milk induced enteropathy associated with occult Gastrointestinal bleeding has been 
implicated as the cause of iron deficiency in some infants. 
· Peptic ulcer disease is a well-documented cause of occult blood loss. 
· Crohn’s disease and ulcerative colitis also are commonly associated with iron 
deficiency. 
· During the first year of life, meckel diverticulum is a well-recognized cause of 
asymptomatic bleeding. 
· Corticosteroids, Indomethacin and other non-steroidal anti-inflammatory agents may 
also induce gastrointestinal tract bleeding  
· Hookworm infestation (Ankylostomiasis) is the most important cause of intestinal 
blood loss  worldwide.  
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The parasites Ankylostoma duodenale and Nectar americanus attach to the proximal 
portion of the small intestine and suck blood from submucosal vessels. The amount of 
blood lost is a  function of the hook wormload, which in turn is proportional to the 
number of ova in the stool. Each  worm has been in the intestine for months or years, 
draws 0.2-0.5 ml of blood per day. It has been  estimated that the loss of 
haemoglobin for every twelve worms may be one percent. Fecal ova  counts in 
excess of 5000/g are regularly associated with iron loss of more than 3to 4 mg/ day and a 
high incidence of iron-deficiency anaemia.  
 
Pathogenesis: 
 Iron deficiency anaemia develops when the supply of iron to the bone marrow is 
insufficient for the requirements of haemoglobin synthesis.  
It has been pointed out that the body is normally in a state of positive iron balance. 
When a negative iron balance occurs due to either blood loss, increased requirements or 
impaired absorption, the deficit is made good by iron mobilized from the tissue stores and 
an adequate supply of iron for haemoglobin formation is maintained. It is only when the 
tissue stores are exhausted and the supply of iron to the marrow for haemoglobin 
synthesis becomes inadequate, hypochromic anaemia develops. 
 
 Thus iron deficiency may be regarded as developing in two stages.  
1. The progressive depletion and cultivate exhaustion of the available tissue iron stores. 
2. The development of anaemia.  
 Iron deficiency state, which may be divided into three functionally distinct stage of 
severity  
 
Stage of Iron deficiency anaemia: 
 
1. Storage iron depletion: 
Iron reserve is small or absent and is characterized by reduced serum ferritin or 
reduced iron concentration in marrow and liver tissue. Haemoglobin serum iron, 
Transferritin concentration and saturation are within normal limits. 
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2.  Iron limited erythropoiesis: 
Haemoglobin (Hb) may still be normal but serum iron is low and TIBC increased with 
a low serum ferritin and raised free erythrocyte protoporphyrin (FEP). 
 
3. Iron deficiency anaemia: 
The flow of iron to erythroid marrow is impaired to cause reduction in haemoglobin 
concentration with a progressive microcytic hypochromic anaemia associated with the 
reduced serum iron, transferrin saturation and serum ferritin level. 
 
CLINICAL FEATURES: 
 
Symptoms Signs 
Weakness 
Headache 
Bodyache 
Giddiness 
Fatigue 
Lassitude 
Breathlessness on exertion 
Dimness of Vision 
Dizziness 
Insomnia 
Inability to concentrate 
Tinnitus 
Anginal pain 
Paraesthesia in fingers and toes 
Palpitation 
Loss of appetite 
Mental apathy 
Constipation 
Abdominal distension 
Hair loss 
Exercise intolerance 
 
Pallor of the skin, mucous membrane, palms, 
nails and conjunctiva 
Smooth, pale, glossy, tongue 
 
Angular stomatitis 
Glossitis 
Cheilosis 
HepatoSplenomegaly 
Koilonychia 
Pica 
Tachycardia 
High volume pulse 
Haemic murmur 
Oedema 
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Epithelial tissue changes 
Long standing IDA causes epithelial tissue changes in some patients. The changes 
occur in the nails (koilonychia or spoon shaped nails), tongue (atrophic glossitis), mouth 
(angular stomatitis) and oesophagus causing dysphagia from development of thin 
membranous webs at the post cricoid area (Plummer Vinson syndrome). 
 
ROLE OF IRON DEFICIENCY ANAEMIA IN VARIOUS SYSTEMS 
 
Cardiovascular system: 
Dyspnoea and palpitation are common symptoms while on exertion but in very 
severe anaemia the patient may get cardiac failure and there may be dyspnoea at rest. 
Haemic murmurs are commonly heard in anaemic patients. The murmurs are most often 
mild systolic murmurs heard at the mitral area. 
Systolic bruits over the carotid arteries in the neck are sometimes present in 
anaemia usually they are bilateral and occur in the absence of an aortic systolic bruit and 
disappear following correction of the anaemia. Jugular venous pressure increase in severe 
anaemia due to the high pulse pressure with a capillary pulsation. Oedema of the legs 
occasionally occurs in ambulant patient with severe anaemia as the result of venous and 
capillary pressure on exertion and increased capillary permeability 
 
Central nervous system: 
Symptoms include faintness, giddiness, headache, roaring and banging in the ears, 
tinnitus, spots before the eyes, lack of concentration and drowsiness and with severe 
anaemia clouding of consciousness, numbness, coldness and sometime tingling of the 
hands and feet. 
 
Reproductive system: 
Menstrual disturbances are commonly associated with anaemia. 
 
Renal system: 
Slight proteinuria may be present with severe anaemia. Anaemia may further 
reduce renal function to the point at which nitrogen retention develops. Correction of 
anaemia in such patient is usually followed by a fall in blood urea. 
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Gastro Intestinal system: 
Anorexia is the commonest symptom, nausea, flatulence and constipation may 
also occur. Slight to moderate smooth hepatomegaly is common is severe anaemia and 
when congestive heart failure develops the liver may become tender. In certain cases of 
iron deficiency anaemia, spleen may be enlarged. 
 
Pyrexia: 
Mild pyrexia may occur with severe anaemia but marked fever is due to either the 
causative disorder or to some complicating factor. 
 
Dietary Iron: 
The dietary iron comes from two sources, Heme and non-heme, the later being the 
major source of iron in diet and is found in varying degrees in all foods of plant origin. 
Heme iron is present in meat, fish, and poultry, but the intake of these products is 
generally low. Heme iron is better absorbed than non-heme iron and is not influenced by 
dietary factors. 
 Breast milk even in spite of low levels of iron (0.5 mg/ lit) has a better absorption 
and bioavailability as compared to cow’s milk. Good sources of iron in the diet includes, 
pulses, dhals, green leafy vegetables, dates, nuts, jaggery, meat and fish. Administration 
of 50 mg of vitamin C increases iron absorption by two folds. 
 
Complications in Iron Deficiency anaemia: 
· Iron deficiency anaemia may be the present finding in gastro intestinal cancer. 
· In patients with heart disease severe anaemia may precipitate angina pectoris or 
congestive heart failure 
· Infections are more common in Iron deficiency anaemia, especially those of the 
respiratory, gastrointestinal and urinary tracts. 
· Chronic iron deficiency anaemia reduces the efficiency in work and study 
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Investigations required for Iron Deficiency anaemia: 
1. Blood Investigations 
Haemoglobin 
Total Red Blood cell count 
Peripheral blood smear 
Packed cell volume 
Mean corpuscular volume 
Mean corpuscular haemoglobin 
Mean corpuscular haemoglobin concentration 
Total iron binding capacity 
 Differential count 
 Erythrocyte sedimentation rate 
 Red cell survival 
 Serum iron 
 Serum Ferritin concentration 
 Serum protein 
 Serum creatinine 
 
2. Urine Investigations 
Urine Sugar 
Urine albumin 
Deposits 
Red blood cells 
Pus cells 
 
3. Stool Investigations 
Ova 
Cyst 
Occult blood 
Red blood cells 
Pus cells 
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Special Investigations occasionally required: 
· X-ray barium meal, X-ray Barium enema, X-ray chest 
· Endoscopy, colonoscopy, sigmoidoscopy, gastro duodenoscopy 
· Isotope studies 
a. Determination of life span of red cells using 51Cr labeled erythrocytes 
b. Determination of absorption, utilization, and disposal of iron using 58Fe 
· Skeletal survey for multiple myeloma and secondary deposits 
· Bone marrow examination 
· Liver Function Test (LFT) 
· Jejunal biopsy, urography, selective angiography 
· Ultrasonography 
 
Laboratory Diagnosis: 
In Iron deficiency anaemia the haemoglobin is less than 11 gm in children. The 
red cell count in rarely below 2.5 million/cubic millimeter and the red cells are usually 
microcytic and hypochromic reticulocytes and platelets are normal or increased. The 
white cell count is normal. Serum iron is usually below 30µg/100ml. (Normal is 250 - 
350µg/100ml). Bone marrow haemosiderin is absent. The PCV, MCV, MCH , MCHC are 
all reduced. 
 
Differential Diagnosis: 
Iron deficiency anaemia must be differentiated from other hypochromic anaemia. 
 
1. Anaemia of infection: 
Chronic infections such as rheumatic fever, rheumatoid arthritis, tuberculosis and 
malaria may have associated mild to moderate anaemia, which is normochromic or 
slightly hypochromic. Serum iron is low, total iron binding capacity is also decreased. 
Bone marrow haemosiderin is present 
2. Pyridoxine (Vit B6) Deficiency anaemia: 
It is characterized by severe hypochromic microcytic anaemia, often early in infancy 
and progressive hepatospleenomegaly. There is elevation of serum iron. Marrow shows 
erythroid hyperplasia with nucleated normoblasts containing iron inclusions, the so-called 
“sideroblasts” in abundance. There are abnormalities of tryptophan metabolism. 
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3. Some Haemoglobinopathies: 
In haemoglobin abnormalities like thalassemia, the red cells are microcytic and 
hypochromic. Thalassemia minor is distinguished by normal serum iron, normal total iron 
binding capacity, decreased mean corpuscular volume, normal serum ferritin and 
transferrin iron saturation. 
4. Sideroblastic anaemia: 
Most of the red cells are hypochromic and microcytic, serum iron is high and iron 
deposit in the marrow, liver and spleen are excessive. Many erythrocytes and 
erythroblasts contain non haemoglobin iron (ringed sideroblasts) in their mitochondria. 
The spleen is usually enlarged. 
5. Anaemia of lead poisoning: 
Anaemia of lead poisoning is hypochromic and microcytic and may be moderate to 
severe. Basophilic stippling of red cells, which helps to differentiate it from iron-
deficiency anaemia, pronounced increase of aminolevulinic acid and coproporphyrin in 
the urine is characteristic of lead poisoning. Increased levels of lead in blood are required 
for definite diagnosis. 
 
Diagnosis: 
Following criteria are essential to diagnose iron deficiency anaemia 
· History of inadequate intake of dietary iron and blood loss if any 
· Typical symptoms and signs like easy fatiguability, pallor, pica, koilonychia, 
smooth tongue, cheilosis and dysphagia associated with general considerations 
· Hypochromic and microcytic structure of red blood cells 
· Low serum iron, increased total iron binding capacity 
· Bone marrow haemosiderin 
· Blood loss usually occult 
· Platelet count is either normal or raised 
· Haemoglobin estimation variably reduced 
· Reduced mean cell volume 
· Erythrocyte count may be normal or reduced less than haemoglobin level would 
suggest 
· Serum ferritin level is reduced 
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MANAGEMENT 
This can be considered under three headings: 
1. Correction of anaemic state: 
 Over all correction of nutrition with articles rich in iron is important. Iron deficiency 
is corrected by intake of rich iron content diet and administration of medical iron. 
2. Replenishment of iron stores 
3. Elimination of the cause 
 
Response to Treatment 
1. A positive response to therapy can be defined as a daily increase in haemoglobin 
concentration of 0.1 gm/dl (0.3 or 1 % increase in haemocrit) from the 4th day 
onwards. 
2. Reticulocytes increase within 3 to 5 days and reach a maximum at 5 to 10 days.  
3. Haemoglobin concentration is virtually normal after 2 months of therapy. However 
food containing iron should be continued for 3 to 6 months to build up iron stores. 
RBC counts may temporarily rise above normal before haemoglobin response. The 
red cell indices may remain abnormal for sometime after the normal haemoglobin 
level has been restored. The microcytic population is gradually replaced by a 
normocytic population. 
4. Pica pagophagia and other nonspecific symptoms disappear within one week of 
therapy. With the onset of treatment the patients shows rapid subjective improvement 
with disappearance of fatiguability, lassitude, and impaired cognitive functions of the 
epithelial lesions those affecting tongue and nails are most responsive to treatment. 
After 1-2 weeks of therapy, small filiform papillae are seen on the tongue. By 3 
months the tongue is usually normal and koilonychia usually disappears within 3 -6 
months. 
 
PREVENTION OF IDA 
Appropriate nutritional strategies are an important factor in prevention of IDA. 
The basic approaches to the prevention of IDA include 
1. Protection and promotion of breast feeding as long as possible along with timely 
weaning is effective in preventing IDA. Low birth weight infants need iron 
supplementation from the age of 2 months. 
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2. Dietary modification and consumption of larger amounts of habitual foods increases 
total iron consumption by 25 – 30 %.  Processes like germination (Sprouting of green 
gram) consumption of green leafy vegetables would be additional long-term methods 
for prevention of IDA. 
3. Periodic de-worming with anti-helminthic drugs for hookworm infestation and 
schistosoma should be considered in endemic areas. 
4. Supplementation with medicinal iron is considered necessary to reduce the extent of 
anaemia in developing countries 
5. Food and salt fortification with iron are evolving rapidly and would be one of the 
most effective ways to control IDA. Salt fortification with iron content of 1 mg per 
gram of salt is the most effective preparation. 
 
Self care Procedures for iron deficiency anaemia 
1. Eat more foods that are good source of iron 
2. Concentrate on green leafy vegetable, red meat, beef liver, poultry, fish, wheat germs, 
oysters, dried fruit and fortified cereals. 
3. Boost iron absorption. Foods high in vitamin C like citrus fruits, tomatoes, and 
strawberries help the body absorbing iron from food. 
4. Red meat not only supplies a good amount of iron, it also increases absorption of iron 
from other food sources. 
5. Take an iron supplement. Consult your physician for proper dosage 
6. While iron is best absorbed when taken on an empty stomach, it can upset your 
stomach. Taking iron with meals is less upsetting to the stomach. 
7. Avoid antacids, phosphates (which are found in soft drinks, beer, ice cream, candy 
bars, etc) and the food additive EDTA. These block iron absorption. 
8. Increase dietary fibre to prevent constipation 
9. Avoid aspirin and products with aspirin 
10. Eat good sources of folic acid daily 
11. These include vegetables like asparagus, sprouts, spinach and lettuce.  
12. Black-eyed peas, cantaloupe orange juice, oatmeal, whole grain cereals, wheat germ, 
liver and other organ meats are excellent sources also 
13. Eat fresh uncooked fruits and vegetables often. Don’t parboil vegetables. Heat 
destroys folic acid. 
Take a multivitamin supplement daily that has 100% of the RDA for folic acid 
deficiencycan lead to infertility and an increased risk of infection. 
 
72 
 
                  DRUG REVIEW  
The Trail Drug is Tirudharatchatha Chooranam(TC) 
 
  INGREDIENTS 
· Munthiri (Anacardium occidentale)-35 gms 
· Pereechu ( Phonex dactilifera ) - 35gms 
· Thippli (Piper longum) - 35gms. 
· Athimathuram ( Glycyrrhiza glabra ) - 35gms 
· Lavangapathri (Cinnamomum tamala) - 35gms 
· Mutha kasu ( Cyperus Rotundus ) - 35gms 
· Kothumalli ( Coriandrum sativum ) - 35gms 
· Kirambu ( Syzygium aromaticum ) - 35gms 
· Nerpori ( Oryza sativa ) - 35gms. 
· Elam (Elettaria cardamomum)-35 gms 
· Kodiveli (Plumpago indica)-35 gms 
· Kookai neeru(Maranta arundiacae)-35 gms 
· Milagu (Piper nigrum) – 35 gms 
· Mutka velai (tephorosia purpurea)-35 gms 
· Sugar – Equal amount of chooranam. 
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1.   தி  
தாவரவ ய  ெபய  : Anacardium occidentale 
   ப  : Anacardiaceae. 
ேவ  ெபய  : ெகா ைட  தி மா, ெகா ல மா. 
 ைவ : இன  . 
த ைம : த ப . 
ப   : இன  . 
 
 
ெச ைக :  
Ø சி ந ெப  கி,  
Ø ெவ ப  டா கி. 
 ண  : ஐ  ல க     ந ைம பய   . 
 
2.  ேப  ச  
தாவரவ ய  ெபய  : Oryza sativa 
   ப  : Arecaceae 
ேவ  ெபய  : ேப  ச , ேப  ைச. 
 ைவ : இன  . 
த ைம : த ப . 
ப   : இன  . 
ெச ைக :  
Ø உட ரமா கி,  
Ø உட ேத றி. 
 ண  :  திைய ெப    ,  திேபா ைக நி    ,  
 
 
3.  ஏல  
தாவரவ ய  ெபய  : Elettaria cardamomum. 
   ப  : Zingiberaceae 
ேவ  ெபய  : இள சி, ேகார க ,  . 
 ைவ : கா   . 
த ைம : ெவ ப . 
ப   : கா   . 
 
ெச ைக :  
Ø ெவ ப  டா கி,  
Ø அக  வ வக றி, 
Ø பசி த    . 
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 ண  : இ , ெதா ைட, தா , கீ வா  இைவகள  உ டா   
ேநா கைள  , இ ம , கழி ச , ந      , சில தி ந   இவ ைற   
ேபா   , அழைல ஆ   .  
 
 
4.  ெகா ேவலி 
தாவரவ ய  ெபய  : Plumpago indica. 
   ப  : Plumbaginaceae. 
ேவ  ெபய  : சி திர ல , ஒலி, சி திர லி, வ ன . 
 ைவ : கா   . 
த ைம : ெவ ப . 
ப   : கா   . 
ெச ைக :  
Ø உரமா கி,  
Ø பசி த    . 
 ண  : இதனா , க  ,   , கழைல, வள ேநா , ேசாைப, உதிர க  , 
ெப  வய  இவ ைற ணப    . 
 
 
5.  ைகந . 
தாவரவ ய  ெபய  : Maranta arundiacae. 
   ப  : Zingiberaceae 
ேவ  ெபய  : அர  கிழ  , வாமா கிழ  , ைககிழ  . 
 ைவ : இன  . 
த ைம : த ப . 
ப   : இன  . 
ெச ைக :  
Ø உட ரமா கி,  
Ø உட ேத றி, 
Ø  ள  சி  ட கி. 
 ண  : இதனா , இ ம , ர , ந ேவ ைக ந   , உட   ஊ ட  
த  . 
6.  மிள . 
தாவரவ ய  ெபய  : Piper nigrum. 
   ப  : Piperaceae. 
ேவ  ெபய  : கலிைன, கறி, காய , திர க , மி ய , ச மப த , 
வ ள ச , மாச ,  மிள , மைலயாள , ேகாளக . 
 ைவ : ைக  , கா   .. 
த ைம : ெவ ப . 
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ப   : கா   . 
ெச ைக :  
Ø காற  ட கி,  
Ø அக  வ வக றி,  
Ø  ைறேவ பக றி, 
Ø த    டா கி. 
 ண  : இதனா , ள   ர , பா  , ேகாைழ, கழி ச ,  ம , வா , 
 ைவய ைம இைவ ேபா  . 
It contain Chavicine, Piperine, Piperidine these alkalodies. 
 
7.   கா  ேவைள. 
தாவரவ ய  ெபய  : tephorosia purpurea. 
   ப  : Favaceae. 
ேவ  ெபய  : கா ேவைள. 
 ைவ : கா   . 
த ைம : ெவ ப . 
ப   : கா   . 
ெச ைக :  
Ø உட ரமா கி,  
Ø ெகாைழயக றி,  
Ø சி ந ெப  கி, 
Ø வ  க   கி, 
Ø மல   வக றி. 
 ண  : இதனா , வாதாதி க  , நாவற சி  , ப  ேநா  , 
ெசா  வ    ேநா   ேபா  . 
 
 
8.  தி ப லி. 
தாவரவ ய  ெபய  : Piper longum. 
   ப  : Piperaceae. 
ேவ  ெபய  : காம , டா , ேகாலக , ேகாலி, சர , சா , மாகதி, 
ைவேதகி, அ  , ஆதி ம   .. 
 ைவ : இன  . 
த ைம : த ப . 
ப   : இன  . 
ெச ைக :  
Ø அக  வ வக றி,  
Ø ெவ ப  டா கி. 
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 ண  : இ , ஐய ப ண கைள அக றி, உட   வ ைமைய அள தி  . 
ஈைள, இ ம , இைர  , உ ப ச  தலிய ப ண கைள ேபா   . 
It contains iperine, alkaloides.  
 
 
9.  அதிம ர . 
தாவரவ ய  ெபய  : Glycyrrhiza glabra. 
   ப  : Favaceae. 
ேவ  ெபய  : அதி க , அ   ம க ,  றிேவ . 
 ைவ : இன  . 
த ைம : சீத . 
ப   : இன  . 
 
ெச ைக :  
Ø வற சியக றி,  
Ø உ ளழலா றி, 
Ø ேகாைழயக றி, 
Ø மலமிள கி, 
Ø உரமா கி. 
 ண  : இ ,  ப ன யா  வ     , ந  ேவ ைக, க  ேநா க ,சி  ந  
எ  ச , காமாைல, ஐய தா  டன ேகாைழைய இளக  ெச   . 
த   ற தி  வ ைமைய  தாழ  ெச   . 
It contain Glycyrrhizin, Glycyrrhizic acid, Glycyrrhetinic Acid. 
 
 
10.  இலவ க ப தி . 
தாவரவ ய  ெபய  : Cinnamomum tamala. 
   ப  : Laraceae. 
ேவ  ெபய  : தாள சப தி , தமாலப தி . 
 ைவ : கா   . 
த ைம : ெவ ப .. 
ப   : கா   . 
ெச ைக :  
Ø அக  வ வக றி,  
Ø ெவ ப  டா கி. 
Ø பசி த    , 
Ø வ ய ைவெப  கி. 
 ண  : ேமக ர , ஐய ர , ெவ ைட, இைர  , இ ம , ந  ேவ ைக, 
அழ , வா தி, தா  ந ட  ேபா   . 
It contain Cinnamic Acid, Tannin. 
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11.   த கா . 
தாவரவ ய  ெபய  : Cyperus rotundus. 
   ப  : Cyperaceae. 
ேவ  ெபய  : ேகாைர. 
 ைவ : . 
த ைம : ெவ ப .. 
ப   : கா   . 
ெச ைக :  
Ø உரமா கி,  
Ø ெவ ப  டா கி. 
Ø  வ  ப , 
Ø சி ந ெப  கி, 
Ø வ ய ைவெப  கி. 
 ண  : இதனா , நள    ர ,  தியழ  ேநா , ரவைகக , 
ந ேவ ைக,  ப ண , ப ததாக  ஆகிய இைவக  ேபா  . 
It contains Starch, Carbohydrate, Pinene, Cineole, Sesquiterpenges, Glycerol, Linolenicacid, 
Linolic acid, Oleic Acid. 
 
 
12.  ெகா  ம லி. 
தாவரவ ய  ெபய  : Coriandrum sativum. 
   ப  : Apiaceae. 
ேவ  ெபய  : உ   அ சி, தன யா. 
 ைவ : கா   . 
த ைம : ெவ ப . 
ப   : கா   . 
ெச ைக :  
Ø அக  வ வக றி,  
Ø ெவ ப  டா கி. 
Ø பசி த    , 
Ø சி ந ெப  கி. 
 ண  : இதனா , ைவய ைம, த  ற தா  வ   ர  தலிய 
இைவ ேபா  . இ  வ ைமைய உ டா   . 
It contain Coriandrol terbine. 
 
13.  கிரா  . 
தாவரவ ய  ெபய  : Syzygium aromaticum. 
   ப  :Myrtaceae. 
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ேவ  ெபய  : அ  க , உ கட , க வா   கிரா  , ேசாச , திரள , 
வரா க .. 
 ைவ : கார   வ வ     ள .. 
த ைம : ெவ ப .. 
ப   : கா   . 
ெச ைக :  
Ø அக  வ வக றி,  
Ø இசிவக றி. 
Ø பசி த    , 
 
 ண  : இ  கிரா  , மய க , ேபதி, வா தி,  தி கழி ச , நா ப ட 
கழி ச , எ வா  க   , ெசவ ேநா , சிவ தம ச , க  தம ச , 
க ண  , பைடக  ஆகியவ ைற ந   . 
 
 
14.  ெந ெபாறி. 
தாவரவ ய  ெபய  : Oryza sativa. 
   ப  : Poaceae. 
ேவ  ெபய  : ேதாைர, ைவ, வ கி, சாலி, வ . 
 ைவ : கா   . 
த ைம : ெவ ப .. 
ப   : கா   . 
ெச ைக :  
Ø உட ரமா கி,  
Ø உ ளழலா றி, 
 ண  : ெந ெபாறிைய க சி கா  சி ேநாயாள க    ெகா  கலா . 
வாய   ேநா  ெவ ைள ர  தலிய ேநா க  ந   . 
 
 
15.  ச  கைர. 
 
தாவரவ ய  ெபய :  Saccharum Officicinarum 
   ப : Poaceae 
ெச ைக :  
Ø உ ளழலா றி, 
Ø அ கலக றி. 
 ண  : உண  ெபா ைள ெகடாம  ைவ க  , ஜலேதாஷ , 
ந ரப  னசேநா  இைவகைள ேபா   . 
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4. MATERIALS AND METHODS 
Pandu is one of the most common problem in Paediatric practice among young 
children  in India. Hence it was proposed to study about the disease. A Protocol was 
prepared  and submitted before IEC & IAEC meeting, a After obtaining approval from 
the commitee, the study Preclinical & clinical study on Pandu Noi (IDA) in children and 
the drug of choice was  Tirudharatchatha Chooranam(TC) was carried out in National 
Institute of Siddha. 
The ingredients for preparation of experimental formulation Tirudharatchatha 
Chooranam was purchased from a well reputed country shop and raw drugs were 
authenticated by Herbal botanist. The medicine was prepared in Gunapadam lab of 
National institute of Siddha after proper purification.The prepared medicine was  also 
authenticated by the concerned Head Of The Dept for its completeness.   
 INGREDIENTS OF TC 
· Munthiri (Anacardium occidentale)-35 gms 
· Pereechu ( Phonex dactilifera ) - 35gms 
· Thippli (Piper longum) - 35gms. 
· Athimathuram ( Glycyrrhiza glabra ) - 35gms 
· Lavangapathri (Cinnamomum tamala) - 35gms 
· Mutha kasu ( Cyperus Rotundus ) - 35gms 
· Kothumalli ( Coriandrum sativum ) - 35gms 
· Kirambu ( Syzygium aromaticum ) - 35gms 
· Nerpori ( Oryza sativa ) - 35gms. 
· Elam (Elettaria cardamomum)-35 gms 
· Kodiveli (Plumpago indica)-35 gms 
· Kookai neeru(Maranta arundiacae)-35 gms 
· Milagu (Piper nigrum) – 35 gms 
· Mutka velai (tephorosia purpurea)-35 gms 
· Sugar – Equal amount of chooranam. 
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4.1 PREPERATION: 
  Except sugar, Pereechu, all the drugs are made into a fine powder by using Iron 
mortar and pestle and then purified. It is then mixed with  Pereechu and equal amount of 
sugar.                                          
   
PURIFICATION:   
All the raw drugs purchased are cleaned finely and the drugs which are to be 
purified by roasting, are roasted in allow heat until it becomes golden brown in colour. 
The drugs to be added in the preparation are grinded separately, filtered in a fine cloth, 
measured separately, then the fine powder (chooranam ) is mixed with cows milk and 
made in to a solid form. Then it is kept in a clean cloth which is tied to the mouth of a 
mud vessel containing equal amount of cow’s milk and water. Then it is finally covered 
over with a top vessel, sides are covered with a cloth, so that vapor does not escape over 
by boiling. After complete boiling of liquid, the solid mixture is taken and dried in sun 
light and grinded finally and equal amount of sugar is added to the chooranam. 
                    
  தி  (Anacardium occidentale)   ேப  ச  ( Phonex dactilifera ) 
                   
ஏல ; (Elettaria cardamomum)   ெகா ேவலி (Plumpago indica)- 
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 ைகந ; (Maranta arundiacae)   மிள  (Piper nigrum) 
          
  கா  ேவைள (tephorosia purpurea)  தி ப லி (Piper longum) 
           
  த கா  ( Cyperus Rotundus )  இலவ க ப தி  (Cinnamomum tamala) 
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ெகா  ம லி ( Coriandrum sativum )     கிரா   ( Syzygium aromaticum ) 
         
ெந ெபாறி ( Oryza sativa )   ச  கைர (Saccharun Officinarum) 
               
அதிம ர ; ( Glycyrrhiza glabra )                         Tirudharatcha chooranam(TC) 
Even though the drugs were pure herb safety of Tirudharatchatha Chooranam by  Acute 
and Sub acute Toxicity studies were done  in animal models according to WHO 
guidelines, 1993. For acute toxicity mice and for subacute toxicity study rat were used. 
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4.2 PRE CLINICAL STUDY 
Method of Toxicity Study 
4.2.1 Preparation of drug for dosing 
 All drugs used for the study was suspended each time with 1% (w/v) solution of 
sodium carboxy methyl cellulose before administration. 
 
4.2.2 Drugs and chemicals 
 All fine chemicals used in these experiments were obtained from Sigma 
Chemicals company, U.S.A. Other analytical grade chemicals were obtained from S.d. 
Fine Chemicals Ltd., Mumbai. 
 
4.2.3 Experimental animals  
 Colony inbred animals strains of wistar rats of either sex weighing 200 - 250 g 
were used for the pharmacological and toxicological studies. The animals were kept 
under standard conditions 12:12 (day/night cycles) at 220C room temperature, in 
polypropylene cages. The animals were fed on standard pelleted diet (Hindustan Lever 
Pvt Ltd., Bangalore) and tap water ad libitum. The animals were housed for one week in 
polypropylene cages prior to the experiments to acclimatize to laboratory conditions. The 
experimental protocol was approved by the Institutional Animal Ethical Committee 
(IAEC). 
4.2.4 Acute oral toxicity study     
Acute oral toxicity was conducted as per the OECD guidelines (Organization of 
Economic Cooperation and Development) 423 (Acute Toxic Class Method). The acute 
toxic class method is a stepwise procedure with 3 animals of a single sex per step. 
Depending on the mortality and /or moribund status of the animals, on the average 2-4 
steps may be necessary to allow judgment on the acute toxicity of the test substance. This 
procedure results in the use of a minimal number of animals while allowing for 
acceptable data based scientific conclusion. 
The method uses defined doses (5, 50, 300, 2000 mg/kg body weight) and the 
results allow a substance to be ranked and classified according to the Globally 
Harmonized System (GHS) for the classification of chemicals which cause acute toxicity 
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Wistar albino rats of either sex weighing 200-250 g were fasted overnight, but 
allowed water ad libitum. Since the formulation is relatively non toxic in clinical practice 
the highest dose of 2000 mg/kg/p.o (as per OECD guidelines “Unclassified”) was used in 
the acute toxicity study.   
The animals were observed closely for behavioural toxicity, if any by using FOB 
(Functional observation battery). 
 
4.2.5 Repeated oral toxicity study  
Repeated oral toxicity studies can be used to get additional information regarding 
the toxicity profile of a chemical. Repeated oral toxicity studies are defined as those 
studies where the chemical is administered to the animal for a period covering 
approximately 10% of the expected life of the animal. Usually, the dose levels are lower 
than for acute studies and allow chemicals to accumulate in the body before lethality 
occurs, if the chemical possess this ability. 
Experimental procedure 
Group I : Control animals received 1%CMC, 10 mg/kg/p.o. for 14 days  
Group II : Aqueous  suspension  of  TC 180mg/kg/po  for 14 days 
Dose calculation: The adult dose (1500mg/day- of TC) is converted into rat dose by 
multiplying the human dose with a factor 0.018 (corresponding to body surface area)to 
get the dose for a rat weighing 200g. Multiply the dose for 200 grams rat x 5 to get the 
dose for kg body weight of the rat. 1000mg x0.018=180mg/200g body weight 
rat,multiply the rat dose for 200g x 5 to get rat dose  for kg body weight. 
 Body weight, food intake and water intake was recorded at two intervals with 
simultaneous observation for toxic manifestation and mortality, if any. At the end of 21 
days treatment all the animals were sacrificed by over dosage of ether anaesthesia. Blood 
was collected and used for haematological studies. Section of liver, kidney, and heart 
were dissected out and kept in 10% formalin for histopathological studies. 
 
4.2.6 Biochemical studies 
Estimation of glucose 
 Glucose was estimated using commercial Glucose estimation kit (Span 
Diagnostics) by the method of Barham et al., (1972) and Tenscher. et al., (1971). 
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Aspartate aminotransferase (AST) 
 Aspartate aminotransferase was estimated using commercial AST kit (Span 
Diagnostics) by the method of Reitman and Frankel (1957). 
Alanine aminotransferase (ALT) 
 Alanine aminotransferase was estimated using commercial AST kit (Span 
Diagnostics) by the method of Reitman and Frankel (1957) 
Alkaline phosphatase (ALP) 
 Alkaline phosphatase was assayed using commercial ALP kit (Span Diagnostics)  by the 
method of King (1934). 
 
Urea   
 Urea was assayed using the commercial kit (Span Diagnostics) by the method of 
Coulambe  et al., (1965). 
 
4.2.7 Haematological studies 
Erythrocyte count 
 Erythocyte count was estimated by Hemocytometer method of Ghai (1995). 
Total Leukocyte Count (WBC) 
 Total Leukocyte Count was estimated by Hemocytometer method of John (1972). 
Haemoglobin  
 Haemoglobin was estimated by method of Ghai (1995). 
4.2.8 Histopathological studies  
 Animals were sacrificed at the end of repeated oral toxicity and tissues were 
processed for histopathological studies 
 
4.2.9 Haematinic study 
One group(n=6)of animals fed with Tirudharatchatha Chooranam (TC) at the dose 
180mg/kg/po for 14days. The hematological parameters were taken before and after the 
administration for 14 days and evaluated form its hematinic activity (table-4). 
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4.3 BIO CHEMICAL ANALYSIS 
Method of Bio Chemical Analysis 
1.1 Test Drugs 
The following formulation used in the study was processed by the methods prescribed in 
standard text books of siddha medicines. 
Tirudharatchatha chooranam (TC) – Book of Agasthiyar vaithiya rathinachurukkam. 
 
1.2.Preliminary phytochemical screening 
Procedure Observation inference 
Test for Calcium : 2 ml of extract 
is taken in a clean test tube. To this 
add 2 ml of  4% ammonium oxide 
solution.   
No white precipitate is 
formed 
Absence of calcium  
Test for Sulphate : 2 ml of the 
extract is added to 5 % barium 
chloride solution. 
white precipitate is 
formed  
Presence of Sulphate  
Test for Chloride : The extract is 
treated with Silver nitrate solution  
 No white precipitate is 
formed 
Absence of Chloride 
Test for carbonate : The 
substance is treated with Conc. 
HCl. 
No effervescence is 
formed  
Absence of carbonate 
Test for Starch : The extract is 
added with weak iodine solution  
Blue colour is formed Presence of starch  
Test for Iron (Ferric) : The 
extract is treated with glacial acetic 
acid and potassium ferrocyanide  
Blue colour is formed Presence of Ferric iron 
Test for Iron (Ferrous) : The 
extract is treated with Conc. HNO3 
and ammonium thiocynate 
Brick red colour is 
formed 
Presence of Ferrous iron 
Test for phosphate : The extract 
is treated with ammonium 
molybdate and conc. HNO3 
Yellow precipitate is 
formed 
Presence of phosphate 
Test for Tannic acid : The Blue black precipitate is Presence of Tannic acid 
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extract is treated with Ferric 
chloride  
formed 
Test for Unsaturation : 1 ml of 
Potassium permanganate 
solution is added to the extract.    
It is getting decolourised  Presence of unsaturated 
compound 
Test for saponins: Dilute 
extract+ 1ml of distilled water 
shake well. 
Froth formation Presence of saponins 
Test for sugars :  
 Benedict method ; 5ml of  
Benedict solution heated gently 
then add 8 drops of diluted 
extract then heated in a boiling 
water bath. 
 
Molisch test; Dilute extract+2 
drops of Molisch+3ml 
conc.H2SO4. 
colour changed 
 
 
 
    
 
 No Reddish violet 
zones appeared 
Indicates the Presence of 
sugar(1+) 
 
 
 
 
 
Absence of carbohydrate 
Test for steroids : Liberman 
Burchard test ; Dilute extract +2 
ml acetic 
anhydride+conc.H2SO4 . 
No Formation of red 
colour  
Absence of steroids 
Test for amino acids: Dilute 
extract +2ml of Ninhydrin’s soln 
Formation of  violet 
colour 
Presence of  amino acids 
Test for proteins: Biuret method ; 
1ml of dilute 
extract+1mlof5%CuSO4+ 
1%NaOH. 
Formation of Violet   
colour 
Presence of proteins 
Test for Flavanoids : Dilute 
extract+ mg  bits+2drops of 
conc.HCl  and gently heated. 
No formation of pink 
colour 
Absence of Flavanoids 
Test for phenol; Dilute 
extract+2drops of FeCl3 soln. 
 No Deep green colour 
is formed 
Absence of phenols 
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After finishing the toxicity studies 40 cases were selected from the OPD & IPD of 
Kuzhandhai Maruthuvam Department, National Institute of Siddha. They were treated 
with the trial drug Tirudharatchatha Chooranam and observed for prognosis clinically. 
CLINICAL STUDY 
 
Study Design & Conduct Of Study 
· Study type: An open clinical study. 
· Study place: OPD & IPD Of Ayothidoss pandithar hospital, National Institute of 
Siddha , Tambaram sanatorium, Chennai-47. 
· Treatment period: 40 Days 
· Study Duration 12 Months 
· Population and sample: 
 
 Population consists of pediatric patients attending OPD & IPD of Ayothidoss 
Pandithar Hospital, National Institute of Siddha, Chennai-47. 
The sample consists of patients of 3 - 12 years of age group fulfilling all the inclusion 
criteria and passing the exclusion criteria mentioned below. 
· Sample size: 40 patients. 
Test for Tannins ; dilute extract 
+2ml of 10%lead acetate add. 
White precipitate 
formed 
Presence of tannins 
Test for alkaloids; 
 Mayer’s method;1ml of dilute 
extract + 1ml reagent. 
 
Dragendroff’s method; 1ml of 
dilute extract+ 1ml of reagent. 
 
Appearance of cream 
colour precipitate 
 
 
 
Appearance of orange 
colour precipitate 
 
Presence of alkaloids 
 
 
 
Presence of alkaloids 
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PATIENT SCREENING 
 
INCLUSION CRITERIA 
EXCLUSION CRITERIA 
 EXCLUDED FROM TRIAL 
METHODOLOGY 
       STUDY NUMBER 
     HISTORY TAKING 
LAB INVESTIGATION 
 TRIAL DRUG  
GIVE GENERAL TREATMENT 
CLINICAL ASSESSMENT 
OUTCOME 
INFORM ABOUT STUDY AND 
TRIAL DRUG 
 INFORMED COSENT FORM 
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SUBJECT SELECTION 
                As and when patients reporting with symptoms of inclusion criteria will be 
subjected to screening test & documented using screening proforma. 
 
     INCLUSION CRITERIA 
 
· Age: 3-12yrs of both sex. 
· Hb level with < 11 gm/dl  for aged 3-6 years and < 12 gm/dl for aged 7-12 years 
· Patient willing to sign the informed consent form 
· Patients who are willing   to give biological samples for lab investigation. 
· Smear showing hypochromic microcytic anemia. 
· Patients with symptoms of pallor of skin, mucous membrane, conjunctiva, nail 
beds, Lassitude, Fatigue, Shortness of breath, Palpitation, Anorexia, Lack of 
interest, Frontal headache. 
 
     EXCLUSION CRITERIA 
 
   a) Based on Parental information and previous reports  
· Congenital heart disease. 
· Patients with chronic disease. 
· Jaundice. 
· Malaria and other haematological disorders 
· Inherited defects. 
 
  b) Based on lab investigation: 
· Smear not showing hypochromic microcytic. 
· Patient not willing to give blood sample for investigation. 
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   WITHDRAWAL CRITERIA 
 
· Intolerance to the drug & development  of adverse reactions such as  
nausea, vomiting, Abdominal  discomfort during trial period. 
· Poor patient compliance & defaulters. 
· Patient turned unwilling to continue in the course of clinical trial. 
· Increase in severity of symptoms. 
 
TREATMENT 
 
 1. MEDICINE NAME :  TIRUDHARATCHATHA CHOORANAM 
 
 2. DOSAGE      
     In Pediatrics:    Age 3-5 yrs – 600mg. 
                                          Age 6-8 yrs- 750mg  
                      Age 9-12 yrs-1gm 
*Dose calculation for pediatric group is based on Height and Weight chart, ICMR, 1990; 
and the formula mentioned in the Essential of medical pharmacology by K.D. Tripathi 
from adult dosage of verukadi ( 1.25 gm – 1.5 gm ).    
         
 3. ADJUVANT :    Honey 
 
 4. DURATION :     40 days.            
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METHODOLOGY 
    STUDY ENROLLMENT: 
· In the  open clinical trial, patients informant reporting at the OPD with the clinical 
symptoms of Pallor of skin, mucous membrane, conjunctiva, & nail beds, Lassitude, 
Fatigue, Shortness of breath, Palpitation, Anorexia, Lack of interest, Frontal headache 
will  be examined clinically for enrolling in the study based on the inclusion and 
exclusion criteria.  
· The patients who are to be enrolled would be informed  about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms 
understandable to the patients informant. 
· After ascertaining the patient’s informant willingness, informed consent would be 
obtained in writing from them in the consent form.  
· All these patients will be given unique registration card in which patient’s 
Registration number of the study, Address, Phone number and Doctors phone number 
etc. will be given, so as to report easily if any complications arise. 
· Complete clinical history, complaints and duration, examination findings all would be 
recorded in the prescribed Proforma in the history and clinical assessment forms 
separately.  
· Patients would be advised to take the trial drug and appropriate dietary advice would 
be given according to the patient’s informant perfect understanding. 
 
CONDUCT OF THE STUDY: 
The trial drug “TIRUDHARATCHATHA CHOORANAM” is given continuously 
for 40 days. Deworming will be done with available OPD medicine for needy patients 
after examining the stools. For OP patients, they should visit the hospital once in 7 days. 
The trial drug will be provided for seven days. The patients are requested to return the 
unconsumed trial drug if any. At each clinical visit clinical assessment is done and 
prognosis is noted..For IP patients medicine will be issued daily by investigator for 3-4 
weeks in IPD and followed OPD for who is not in a situation to stay in the hospital for a 
long time.  Laboratory investigations are done 0 day & 40th day of the trial. After the end 
of the treatment also, the patient is advised to visit the OPD for another 2 months for 
follow-up. If any trial patient who fails to collect the trial drug on the prescribed day but 
wants to continue in the trial from the next day or two, he/ she will be allowed, but 
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defaulters of one week and more will not be allowed to continue and be withdrawn from 
the study with fresh case being inducted. 
 
DATA MANAGEMENT: 
· After enrolling the patient in the study, a separate file for each patient will be opened 
and all forms will be filed in the file. Study No. and Patient No. will be entered on the 
top of file for easy identification. Whenever study patient visits OPD during the study 
period, the respective patient file will be taken and necessary recordings will be made 
at the assessment form or other suitable form. 
· The screening forms will be filed separately. 
· The Data recordings in all forms will be monitored and scrutinized by HOD, Dept of 
Kuzhanthai Maruthuvam. 
Data analysis will be done with the help of senior research officer (statistics) of NIS 
 
OUTCOME 
· Primary – Results and observation during the study inclusive of clinical improvement 
etc. 
· Secondary – Efficacy of the trail drug and its side effects if any.  
 
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT: 
                                     If the trial patient develops any adverse reaction, he/she would be 
immediately withdrawn from the trial and proper management will be given in OPD of 
National institute of siddha. 
 
ETHICAL ISSUES: 
1. To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of lab equipments 
will be used.                         
2. No other external or internal medicines will be used. There will be no 
infringement on the rights of patient.    
3. 3.The data collected from the patient informant will be kept       confidentially.The 
patient informant will be informed about the diagnosis, treatment and follow-up.  
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4. After the consent of the patient informant (through consent form) they will be 
enrolled in the study.  
5. Informed consent will be obtained from the patient informant explaining in the 
understandable language to the patient. 
6. Treatment would be provided free of cost.  
7. In conditions of treatment failure, adverse reactions, patients will be given 
alternative treatment at the National Institute of Siddha with full care throughout 
the end.                                                           
 
ASSESSMENT FORMS 
 
FORM I  - SCREENING & SELECTION PROFORMA 
FORM II  - CONSENT FORM 
FORM III  - HISTORY PROFORMA  
FORM IV  - CLINICAL ASSESSMENT FORM 
FORM V  - LABORATORY INVESTIGATION FORM 
FORM VI  - PATIENT’S INFORMATION SHEET  
FORM VII       - WITHDRAWAL FORM 
FORM VIII  - ADVERSE REACTION FORM 
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    5. RESULTS AND OBSERVATIONS 
 
Pre Clinical Study Results 
5.1 Acute oral toxicity study 
TC at the dose of 2000mg/kg/po did not exhibit any mortality in rats. As per 
OECD 423 guidelines the dose is said to be “Unclassified” under the toxicity scale. 
Hence further study with higher doses was not executed.  
 
5.2 Repeated oral toxicity for 14 days 
Test drug TC   at the dose of 180 mg/kg/po when administered orally 14days in 
rats did not show toxicity in renal and Hematological parameters (Table 1). However  
hematological studies showed an increased HB% and total RBC count. Liver and kidney 
function biomarkers level were normal in drug treated rats when compared with control. 
The drug administration for 14 days did not alter the physiological levels of glucose and 
cholesterol in serum (Table 2 and 3).  
 
5.3 Histopathological study 
TC at the dose of 180mg/kg/po daily administered for 14 days did not show 
evidence of pathological lesions in the tissues tested  
 
5.4 Haematinic effect 
TC at the dose of 180mg/kg/po given for 14 days exhibited significant improvement in 
the RBC,Hb%Differential count, and  MCV when compared to control animals 
The test drug did not exhibit mortality at the dose of 2000 mg/kg/p.o. According 
to OECD 423, drugs do not show mortality at 2000 mg/kg and above are “Unclassified” 
under the toxicity scale. Hence further studies with higher doses were not attempted.  
In repeated oral toxicity study (180/kg/p.o) for 14 days animals treated with TC  
did exhibit significant changes in Hb%, and  RBC without any change in  blood sugar, 
cholesterol, body weight, food and water intake and behavioural parameters when 
compared to control animals. TC did not alter Liver and kidney marker enzyme status 
when compared to control animals. .  
The reverse pharmacological studies of TC have got good correlation with clinical 
study report presented in this thesis. The present study also shows the safety profile of the 
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drug in repeated dosing for 14 days Oral drug treatment for 14 days did not exhibit any 
alteration in the biomarkers of kidney. And liver The drug treatment for 14 days 
significantly improved the HB% and its use in the  treatment  of anemia is justified 
through this study. Since the drug elemental iron the administration of the drug for 
14days at the dose of 180mg/kg/po showed significant improvement in the Hb%,clearly 
shows its therapeutic value in the iron deficiency anemia. 
 
Table 1 
  Preliminary acid, basic radicals and phytochemical screening 
S.No. Constituents TC 
1. Calcium - 
2. Iron (Ferric) + 
3. Iron (Ferrous) + 
4. Sulphate + 
5. Chloride - 
6. Carbonate  + 
7. Starch + 
8. Phosphate + 
9. 
10. Unsaturated + 
11. Sugar + 
12. Alkaloids + 
13. Steroids - 
14. Protein + 
15. Tannins + 
16. Phenols - 
17. Flavanoids - 
18. Saponins + 
19. Amino acid + 
20. Glycosides - 
21 Sterols - 
( + ) – Present  
( - )  -  Absent 
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Table-2 
Effect of Siddha Formulations TC  on Haematological parameters after 14 days 
repeated oral dosing  
Grou
ps 
Hb 
(gm/100
ml) 
RBC 
(millions/cu.
mm) 
WBC 
(cells/cu.m
m) 
Differential leucocyte count (%) 
Lymphocy
tes 
Monocy
tes 
Granulocy
tes 
Contr
ol 
12.08±0.3
48 
5.20±0.347 5583.33±33
4.94 
78.00±3.89 5.50±1.0
4 
16.66±3.07 
TC 13.22±0.2
4 ** 
6.27±0.53 * 6043.±349.2
3 ** 
78.33±4.32 
ns 
6.00±2.2
8 ns 
17.5±4.27 
ns 
 
 n=6; Values are expressed as mean ± S.D followed by Students Paired ‘T’ Test 
ns – non significant when compared to control groups 
***p<0.001 **p<0.01 
Table-3       
Effect of Siddha formulation  TC on Biochemical markers of liver and kidney after 
14days repeated oral dosing in rats  
Groups ALP 
 
(K.A.Units) 
AST  
(IU/L) 
SGOT 
ALT  
(IU/L) 
SGPT 
Urea 
 
(mg/100ml) 
BUN 
(mg/ 
100ml) 
Glucose 
Mg.dl 
Cholestrol 
Mg/dl 
Control 2.973 
±0.3929 
79.89 
±1.906 
25.48 
±2.93 
16.38 
±2.12 
7.52 
±0.84 
85.06 
±5.34 
57.64 
±4.54 
Test  
drug 
TC 
2.850 
±0.2074 ns 
82.3 
±5.164 
ns 
24.75 
±0.88 
ns 
16.93 
±0.79 ns 
7.92 
±0.37ns 
89.23 
±10.21ns 
64.07 
±2.73ns 
 
n=6; Values are expressed as mean ± S.D followed by Students Paired ‘T’ Test 
ns – non significant when compared to control groups 
 
Groups PCV % MCV MCH 
Control 29.89 ± 1.16  90.02 ± 0.47 32.83 ± 0.11 
TC 37.0 ± 0.43** 95.54 ± 1.09** 37.43 ± 0.52 ** 
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Table-4 
Effect of Siddha Formulations TC  on Haematological parameters after 21 days 
treatment 
 
Grou
ps 
Hb 
(gm/100
ml) 
RBC 
(millions/cu.
mm) 
WBC 
(cells/cu.m
m) 
Differential leucocyte count (%) 
Lymphocy
tes 
Monocy
tes 
Granulocy
tes 
Contr
ol 
12.08±0.3
48 
5.20±0.347 5583.33±33
4.94 
78.00±3.89 5.50±1.0
4 
16.66±3.07 
TC 14.52±0.7
4 *** 
7.54±0.55 *** 6432.±152.2
3 ** 
80.37±4.12 
ns 
5.00±2.8
8 ns 
16.2±2.12 
ns 
 
 
Haematological Parameter 
12.08
14.52
5.2
7.54 
0
2
4
6
8
10
12
14
16
Control TC 
Grams
Hb
RBC 
100 
 
Observations  
For this clinical study 40 cases were selected and treated in the In-patient 
department and Out-patient department of Ayothidoss Pandithar Hospital, National 
Institute of Siddha, Chennai-47. Results were observed with respect to the following 
criteria. 
 
1. Sex distribution 
2. Age distribution 
3. Religion distribution 
4. Family distribution 
5. Socio-economic status 
6. Dietary habits 
7. Reference to Etiological factors 
8. Seasonal Reference 
9. Reference to Thinai 
10. Reference to Ezhu udal kattugal 
11. Reference to Ennvagai thervukakl 
12. Neerkkuri and Neikkuri reference 
13. Signs and symptoms of Pandu noi during admission and discharge 
14. Statistical  analysis 
15. Results after treatment 
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The observation recorded are given below in tabular form 
 
1. Sex distribution 
S. No Sex No of cases Percentage 
1 Male child 18 45 
2 Female child 22 55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Among the 40 cases treated 18 patients were male children and 22 were female children. 
The percentage is more in the case of female children 
 
 
. 
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2. Age distribution 
S. 
No 
Age 
No of 
cases 
Percentage 
1 1 – 6 months (Kaappu paruvam) - - 
2 7 – 12 months (Senkeerai paruvam) - - 
3 
1 – 3 years (Thalattu, Sappani, Mutha and Varugai 
paruvams) 
3 7.5 
4 4 – 6 years (Pillai paruvam) 14 35 
5 
7 – 12 years (Siruparuvam-male child. Paethai and 
Pethumbai – female child) 
23 57.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Among the 40 cases treated 14 cases (35%) belonged to 4- 6 years and 23 cases (57.5%) 
belonged to 6- 12 years. The percentage is more in the age group of 6 – 12 years. 
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3. Religion distribution 
S. No Religion No of cases Percentage 
1 Hindu 34 85 
2   Christian 2 5 
3 Muslim 4 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Out of 40 cases, 34 cases (85%) belonged to Hindu, 2cases (5%) from Christian religion 
and 4 cases (10%) belonged to Muslim. 
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4. Family Distribution 
 
S. No Family History No of cases Percentage 
1 Positive - - 
2 Negative 40 100 
 
 
All the 40 cases had negative family history 
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5. Socio-economic status 
S. No Economic Status No of cases Percentage 
1 Poor 26 65 
2            Middle class 9 22.5 
3 Rich 5 12.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
Out of 40 cases, 26 cases belonged to poor socio-economic status. 
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6. Dietary habits 
S. No Diet No of cases Percentage 
1 Vegetarian 12 30 
2 Mixed 28 70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
70 % of cases belonged to mixed diet and 30% belonged to vegetarian diet habits. 
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7. Etiological factors 
S. No Etiological factors No of cases Percentage 
1 Nutritional deficiency 45 100 
2 Worm infestation - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Out of 45 cases treated, the etiological factor was found to be nutritional  
deficiency in 100% cases. 
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8. Seasonal Referance 
S. No Paruva kaalam No of cases Percentage 
1 Kaar(Avani, Purattasi) 20 50 
2 Koothir(Iypasi, Karthigai) 12 30 
3 Munpani(Margali, Thai) - - 
4 Pinpani(Masi, Pankuni) - - 
5 Elavenil(Chithirai, Vaikasi) 3 7.5 
6 Mudhuvenil(Aani, Aadi) 5 12.5 
 
       
 
 
 
9.  
 
 
 
 
 
 
 
10.  
 
Among the 40 cases, 20 cases (50%), Belonged to Kaarkalam, 12 Cases (30%) 
Belonged to Koothir Kalam, 3 Cases (7.5%), Belonged to Elavenil Kalam, 5 Cases 
(12.5%), Belonged to Mudhuvenil Kalam. The percentage is more in the kaar and 
Koothir kalam. 
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9. Thinai reference 
S. No Thinai No of cases Percentage 
1 Kurinji (Hill area) 13 32.5 
2 Mullai (Forest area) 6 15 
3 Marutham (Fertile area) 7 17.5 
4 Neithal (Coastal area) 14 35 
5 Paalai (Desert area) - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
Among the 40 cases, 32.5 % belonged to Kurinji nilam, 15 % belonged to Mullai nilam, 
17.5 % belonged to Marutham nilam and 35 % belonged to Neithal nilam. 
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10.  Reference to Udal kattugal 
S. No Udal kattugal No of cases Percentage 
1 Saaram 40 100 
2 Senner 40 100 
3 Oon - - 
4 Kozhuppu - - 
5 Enbu - - 
6 Moolai - - 
7 Sukkilam/suronitham Not applicable Not applicable 
 
 
Regarding seven Udal kattugal, Saaram and Senner were affected in all 40 patients100% 
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11.Reference to Mukkutram 
a. Affected Vatham 
S. No Vatham No of cases Percentage 
1 Pranan 10 25 
2 Abanan 8 20 
3 Viyanan 40 100 
4 Uthanan - - 
5 Samanan 40 100 
6 Naagan 20 50 
7 Koormam - - 
8 Kirukaran 39 97.5 
9 Devathathan 40 100 
10 Dhananjeyan Not Applicable Not Applicable 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Among 10 types of Vatham Pranan, Abanan, Viyanan, Samanan, Naagan, Kirukaran and 
Devathathan were affected. 
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b. affected  Pitham 
S. No Pitham No of cases Percentage 
1 Analam 40 100 
2 Ranjagam 40 100 
3 Saathagam 40 100 
4 Alosagam - - 
5 Pirasagam 40 100 
 
 
 
Among 5 types of pitham all were affected except Alosagam in all patients.  
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c. Affected  Kabam 
S. No Kabam No of cases Percentage 
1 Avalambagam 8 20 
2 Kilethagam 40 100 
3 Pothagam - - 
4 Tharpagam - - 
5 Santhigam 14 35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Avalambagam was affected in 8 cases, Kilethagam was affected in all the cases. And 
Santhigam was affected in 14 cases.  
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12. Reference to Ennvagai thervukal 
S. No Ennvagai thervukal No of cases Percentage 
1 Naadi: Vathapitham 
            Pithavatham 
            Pithakabam 
21 
12 
7 
52.5 
30 
17.5 
2 Sparisam 40 100 
3 Naa 40 100 
4 Niram 40 100 
5 Mozhi - - 
6 Vizhi 40 100 
7 Malam 8 20 
8 Moothiram 13 32.5 
 
Among the Ennvagai thervukal, Naa, Niram Vizhi and Sparisam were affected in all the 
cases (100%) 
 
13.Reference to Neerkuri Neikuri 
S. No Type of test No of cases Percentage 
1 Neerkuri 18              45 
2 Neikuri 
     Ring(azhi) form 
     Pearl (muthu) form 
 
27 
13 
 
67.5 
32.5 
 
Out of 40 Cases 27 cases (67.5%) belonged to Ring(azhi) form, 13 cases (32.5%), 
belonged to Pearl (muthu) form 
 
14. Seasonal Reference 
S. No Kaalam No of cases Percentage 
1 Vatham 40 100 
2 Pitham - - 
3 Kabam - - 
 
All the cases were in Vatha kaalam 
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15.Reference to signs and symptoms 
S. No Signs and symptoms During Admission 
No of cases 
During discharge 
No of cases 
1 Pallor of conjunctiva and 
nail beds 
40 10 
2 Anorexia 40 - 
3 Lassitude 40 5 
4 Ulceration of mouth 1 - 
5 Constipation 8 - 
6 Headache 12 3 
7 Dysnoea on exertion 7 2 
8 Palpitation 5 2 
9 Lack of Interest 21 5 
10 Joint Pain 13 2 
 
             
Regarding science and symptoms pailor, anorexia, lassitude were percentage in all 40 
patient (100%) 
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16. Statistical analysis 
 
Paried – t test is used to determine the significance of treatment before and after on Hb. 
---------------------------------------------------------------------------------------- 
Variable |Obs   Mean       Std. Err.     Std. Dev.     [95% Conf. Interval] 
---------+------------------------------------------------------------------------------ 
hbbt |      40      8.9834    .1501941    1.062027    8.681575    9.285225 
hbat |      40      11.523    .1349842    .9544819    11.25682    11.79926 
---------+------------------------------------------------------------------------------ 
diff |      50     -2.5396    .0152099    .1075451   -2.575245   -2.514035 
 
Ho: mean(hbbt - hbat) = mean(diff) = 0 
 
  Ha: mean(diff) < 0         Ha: mean(diff) ~= 0        Ha: mean(diff) > 0 
       t = -18.3361                t = -18.3361                   t = -18.3361 
   P < t =   0.0000             P > |t| =   0.0000               P > t =   1.0000 
 
There is significant difference between before and after treatment on Hb 
(P<0.0001) 
 
17. Results after treatment 
 
Results were observed on the basis of two main criteria. One on the basis of 
clinical improvement and the other on the results derived from the blood picture. 
 
a.Results from clinical improvement  
Good, moderate, mild improvements were assessed on the basis of relived signs 
and symptoms as follows 
 
Good improvement        
Anorexia-nil 
.  Lassitude-nil 
                        Pallor of conjunctiva and nail beds-nil 
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                        Dyspnoea on exertion-nil 
                        Lack of interest –improved 
 
      Moderate improvement                           
     Anorexia-nil 
                            Lassitude-nil 
                            Pallor of conjunctiva and nail beds - improved 
                             Dyspnoea on exertion - moderately improved 
                             Lack of interest – slightly improved 
 
Mild improvement                           
     Anorexia-nil 
                            Lassitude – on & off 
                            Pallor of conjunctiva and nail beds - present 
                             Dyspnoea on exertion - present 
                             Lack of interest –present 
Among the 40 cases, 24 cases assessed as  good improment,10 cases assessed as 
moderate improvement and 6 cases assessed as  mild improvement. 
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b) Results derived from the blood picture 
Among the 40 cases 24 cases showed hemoglobin 11.5 – 13 gms/dl, 10 cases 
showed hemoglobin 11 – 11.9 gms/dl and 6cases showed hemoglobin 10 – 11 gms/dl. 
Among  the 40 cases studies the results were observed as follows 
S. No Results No of cases Percentage 
1 Good 24 60 
2 Fair 10 25 
3 Poor 6 15 
 
 
 
 
 
 
 
 
 
 
 
 
Among the 40 cases treated, 24 cases 70%) showed good result, 10 cases (25%) showed 
fair result and 6 cases (15%) showed poor result. The results were based on clinical 
improvement and results derived from the blood picture. 
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BLOOD INVESTIGATION BEFORE TREATMENT 
S.No 
OPD 
Number 
Name of the    
Patient Age/ Sex 
HB-
gm/dL 
TC-
Cells/µl 
DC in % PCV-
% 
MCV-
fL 
MCH-
pg 
MCHC-
gm/dL 
PLC-
Lakhs/µl 
TRBC-C 
millions/µl 
SemearStudy 
Semear 
For MP 
RBC WBC 
1 C94839 R.Bagyalakshmi 12/FC 9.7 10000 P-50,L-41,E-6,M-3 32 71.6 24.6 33.4 4.5 3.8 HypochromicMicrocytic 
Normal 
Morphology NIL 
2 C95982 R.Jeevika 09/FC 9 5500 P-31,L-55,E-12,M-2 34.4 80.8 26.8 34.2 3.8 2.3 HypochromicMicrocytic 
Normal 
Morphology NIL 
3 D006722 P.Maheswaran 12/MC 9.1 7500 P-65,L-30E-4,M-1 35.1 72.8 24.1 33 3 3 HypochromicMicrocytic 
Normal 
Morphology NIL 
4 C61851 T.Kishorekumar 05/MC 9.8 9300 P-68,L-23,E-18,M-1 35.6 77.4 27.8 36 2.7 3.6 HypochromicMicrocytic 
Normal 
Morphology NIL 
5 D003289 Vishnupriya 12/FC 10.4 7200 P-45,L-44,E-5,M-1 38.5 81.1 29.1 35.8 3 3.7 HypochromicMicrocytic 
Normal 
Morphology NIL 
6 B64682 Nareshkumar 06/MC 9.8 10600 P-40,L-54,E-6 25.5 60.6 18.6 26.6 2.5 3.36 HypochromicMicrocytic 
Normal 
Morphology NIL 
7 D004178 S.Keerthika 08/FC 9 7500 P-50,L-44E-0.6 32.2 68.8 22.4 32.6 3.2 3.6 HypochromicMicrocytic 
Normal 
Morphology NIL 
8 D004179 S.Mukesh 07/MC 9.5 8200 P-43,L-52,E-0.5 36.8 76.5 27.2 35.6 2.9 3.8 HypochromicMicrocytic 
Normal 
Morphology NIL 
9 C88766 V.PratheepKanna 12/MC 9 7000 P-58,L-36,E-4,M-2 36 68.5 78.5 23.5 2.3 2.9 HypochromicMicrocytic 
Normal 
Morphology NIL 
10 D004763 S.Arun 12/MC 8.9 9000 P-40,L-54,E-6 35.6 81.3 29.5 26.2 2.3 3.3 HypochromicMicrocytic 
Normal 
Morphology NIL 
11 C98887 S.Iswaraya 04/FC 9.5 8500 P-49,L-46E-5, 30 68.9 20.9 34.1 4 3.6 HypochromicMicrocytic 
Normal 
Morphology NIL 
12 C96477 V.Krithika 09/FC 8.3 10000 P-51,L-40,E-6M-3 23 61 24 23.2 4.5 3.1 HypochromicMicrocytic 
Normal 
Morphology NIL 
13 D00157 G.Praveen 04/MC 9.3 11800 P-39,L-49E-11,M-1 22 65 25 22.3 4 3.6 HypochromicMicrocytic 
Normal 
Morphology NIL 
14 C87217 E.Pavithra 03/MC 9.3 14900 P-405,L-55,E-5 35.4 77.8 27 34 2.1 3.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
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BLOOD INVESTIGATION BEFORE TREATMENT 
S.N
o 
OPD 
Number 
Name of the    
Patient Age/Sex 
HB-
gm/dL 
TC-
Cells/µl 
DC in% PCV-
% 
MCV
-fL 
MCH
-pg 
MCHC
-gm/dL 
PLC-
Lakhs/
µl 
TRBC-C 
millions/
µl 
SemearStudy 
Semear 
For MP 
RBC WBC 
15 C95889 J.Gouthaman 05/MC 9..a6 10300 P-28,L-70,E-2 37.8 76.1 28.2 37 1.3 3.8 HypochromicMicrocytic 
Normal 
Morphology NIL 
16 B64681 Lavanya 10/FC 10 6000 P-46,L-50,E-4 36.9 82.4 29.9 30.3 2.2 4.4 HypochromicMicrocytic 
Normal 
Morphology NIL 
17 C95982 I.Ajeera 04/FC 9.5 10700 P-63,L-32,P-4,M-1 35.9 78.7 26.8 34 4.5 4.1 HypochromicMicrocytic 
Normal 
Morphology NIL 
18 C89216 V.Vijayalakshmi 03/FC 10.8 15500 P-31,L-48,E-20,M-1 33.2 71.9 23.4 32.5 4.7 4 HypochromicMicrocytic 
Normal 
Morphology NIL 
19 C89215 V.Rajeswari 06/FC 8.9 12700 P-60,L-45,E-5 32.5 68.3 19.3 28.3 6.9 4.2 HypochromicMicrocytic 
Normal 
Morphology NIL 
20 D003075 N.Prasath 11/MC 7.9 9800 P-54,L-43,E-3 31.6 62.1 18.3 29.4 3.1 5 HypochromicMicrocytic 
Normal 
Morphology NIL 
21 D006422 S.Deepikasri 04/FC 10 8000 P-63,L-37 30.6 62.1 17.3 25.2 1.8 3.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
22 D003905 J.Pooja 11/FC 9.8 9000 p-52,L-43,E-5 28.4 71.2 17.5 23.9 2 3.6 HypochromicMicrocytic 
Normal 
Morphology NIL 
23 C88373 M.Mathivanan 12/MC 9.5 6200 P-60,L-35,E-5 25.9 68.9 27 34.3 2.9 4 HypochromicMicrocytic 
Normal 
Morphology NIL 
24 C98659 E.Motheswaran 07/MC 9.5 9800 P-66,L-30,E-4 34.2 74.5 25.8 33 4.9 4.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
25 D008631 F.NaveenSingh 12/MC 8.5 6800 P-60,L-36,E-4 29 33 68 34.5 4.7 3.9 HypochromicMicrocytic 
Normal 
Morphology NIL 
26 C099668 E.Dhanusree 10/FC 9.5 7700 P-41,L-52,E-6,M-1 34.3 15.4 26.8 35.6 3.2 4.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
27 C48120 S.AbdhulHalad 05/FC 10 8300 p-40,L-54,E-6 30.6 63.9 14.7 23.4 2.6 3.2 HypochromicMicrocytic 
Normal 
Morphology NIL 
28 C86040 T.Kaviya 03/FC 9 13400 P-32,L-60,E-7,M-1 30 62 13.8 24 2.7 3.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
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BLOOD INVESTIGATION BEFORE TREATMENT 
S. 
No OPD Number 
Name of the    
Patient 
Age/ 
Sex 
HB-
gm/dL 
TC-
Cells/µl 
DC in %   PCV-
% 
MCV
-fL 
MCH
-pg 
MCHC
-gm/dL 
PLC-
Lakhs/
µl 
TRBC-C 
millions/
µl 
SemearStudy Semear 
For MP RBC WBC 
29 C85039 T.Balaji 07/MC 9.5 9200 P-53,L-37,E-I0 37.8 76.1 28.2 37 1.3 3.8 HypochromicMicrocytic 
Normal 
Morphology NIL 
30 D006423 S.Datchanasri 04/FC 9.5 10800 P-40,L-40,E-20 30.6 62.1 17.3 25.2 1.8 3.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
31 C97014 R.E.SanjaKannan 12/MC 10.2 15400 P-32,L-47,E-20,M-1 33.3 71.8 21.4 32.6 4.5 4.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
32 C66400 C.Nivethana 10/FC 9.2 7800 P-50,L-42,E-8 36.9 74.4 27.5 35.5 2.4 4.7 HypochromicMicrocytic 
Normal 
Morphology NIL 
33 C099077 A.AshokKumar 05/MC 9 11400 P-34,L-55,E-11 36.3 76.4 28 36.6 4.1 4.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
34 C69026 C.Abitha 05/FC 8.5 6800 P-60,L-36,E-4 29 33 68 34.5 4.7 3.9 HypochromicMicrocytic 
Normal 
Morphology NIL 
35 D002812 M.AravindBala 07/MC 9.6 7400 P-38,L-49,E-13 35 81.4 28.1 34 2.9 4.1 HypochromicMicrocytic 
Normal 
Morphology NIL 
36 D005107 M.Parthiban 06/MC 8.8 5800 P-40,L-56,E-4 37.4 76.3 27.6 35 2.4 3.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
37 C91731 K.Lakshmi 11/FC 9 11000 P-46,L-44,E-10 32.7 70.6 18.3 35.3 3.4 4.2 HypochromicMicrocytic 
Normal 
Morphology NIL 
38 IPD Number 1017 A.Akshaya 09/FC 10.4 7600 P-39,L-58,E-3 34.3 15.4 26.8 35.6 3.2 4.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
39 IPD Number 1027 S.Shobana 04/FC 8.5 10900 P-18,L-77,E-5 29 33 68 34.5 4.7 3.9 HypochromicMicrocytic 
Normal 
Morphology NIL 
40 C54677 Umapriyaa 10/FC 9 13400 P-32,L-60,E-7,M-1 30 62 13.8 24 2.7 3.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
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BLOOD INVESTIGATION AFTER TREATMENT 
S.No 
OPD 
Number 
Name of the    
Patient Age/Sex 
HB-
gm/dL 
TC-
Cells/µl 
DC in % PCV-
% 
MCV-
fL 
MCH-
pg 
MCHC-
gm/dL 
PLC-
Lakhs/µl 
TRBC-C 
millions/
µl 
SemearStudy Semear 
For MP 
RBC WBC 
1 C94839 R.Bagyalakshmi 12/FC 12.7 10300 P-52,L-40,E-6,M-3 33 72 25.6 34.4 4.7 4.5 NormochromicNormo cytic 
Normal 
Morphology NIL 
2 C95982 R.Jeevika 09/FC 9 5800 P-33,L-53,E-12,M-2 35.4 81 27.8 35.2 3.9 3.5 Hypochromic Microcytic 
Normal 
Morphology NIL 
3 D006722 P.Maheswaran 12/MC 12 7700 P-66,L-31E-3,M-1 36.1 79 25.1 34.2 3.5 4.2 Hypochromic Microcytic 
Normal 
Morphology NIL 
4 C61851 T.Kishorekumar 05/MC 11 9500 P-68,L-22,E-8,M-2 35.9 78 28.8 37.4 2.9 4 NormochromicNormo cytic 
Normal 
Morphology NIL 
5 D003289 Vishnupriya 12/FC 9.8 7400 P-46,L-42,E-6,M-1 39 82 30.1 36.8 3.6 3.9 Hypochromic Microcytic 
Normal 
Morphology NIL 
6 B64682 Nareshkumar 06/MC 11 10800 P-43,L-50,E-7 27.5 61 19.6 27.6 2.8 4 Hypochromic Microcytic 
Normal 
Morphology NIL 
7 D004178 S.Keerthika 08/FC 9 7900 P-50,L-43E-,6,M-1 33.2 69 23.4 33.6 3.3 3.7 NormochromicNormo cytic 
Normal 
Morphology NIL 
8 D004179 S.Mukesh 07/MC 9.5 8500 P-45,L-50,E-5 37.2 77 28.2 34.6 3 3.8 Hypochromic Microcytic 
Normal 
Morphology NIL 
9 C88766 V.PratheepKanna 12/MC 11 7500 P-60,L-34,E-5,M-1 36.5 69 79.5 24.5 2.8 3.5 Hypochromic Microcytic 
Normal 
Morphology NIL 
10 D004763 S.Arun 12/MC 12.5 9300 P-40,L-54,E-6 36 82 30.5 27.2 2.7 4.5 NormochromicNormo cytic 
Normal 
Morphology NIL 
11 C98887 S.Iswaraya 04/FC 12.5 8700 P-50,L-47E-4 33 69 22.9 36.1 4.3 4.5 NormochromicNormo cytic 
Normal 
Morphology NIL 
12 C96477 V.Krithika 09/FC 11.1 10500 P-50,L-41,E-7M-2 26 62 26 24.2 4.7 4 Hypochromic Microcytic 
Normal 
Morphology NIL 
13 D00157 G.Praveen 04/MC 12.8 11500 P-40,L-50E-9,M-1 24 66 28 23.3 4.5 4.2 NormochromicNormo cytic 
Normal 
Morphology NIL 
14 C87217 E.Pavithra 03/MC 11.8 15100 P-42,L-53,E-5 35 78 29 35 3.1 4 NormochromicNormo cytic 
Normal 
Morphology NIL 
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BLOOD INVESTIGATION AFTER TREATMENT 
S.No 
OPD 
Number 
Name of the    
Patient Age/Sex 
HB-
gm/dL 
TC-
Cells/µl 
DC in% PCV-
% 
MCV-
fL 
MCH-
pg 
MCHC-
gm/dL 
PLC-
Lakhs/µl 
TRBC-C 
millions/µl 
SemearStudy 
Semear For MP 
RBC WBC 
15 C95889 J.Gouthaman 05/MC 12.6 10500 P-30,L-68,E-2 38 77 28.6 37.9 1.8 4.3 Hypochromic Microcytic 
Normal 
Morphology NIL 
16 B64681 Lavanya 10/FC 12.5 6300 P-48,L-48,E-4 37.5 82.4 30 30.6 2 4.5 NormochromicNormo cytic 
Normal 
Morphology NIL 
17 C95982 I.Ajeera 04/FC 10.5 10900 P-64,L-31E-4,M-1 36 79 27.8 34.5 4.2 4 Hypochromic Microcytic 
Normal 
Morphology NIL 
18 C89216 V.Vijayalakshmi 03/FC 9.5 15800 P-33,L-46,E-19,M-2 34 72 24 33 4.8 3.8 Hypochromic Microcytic 
Normal 
Morphology NIL 
19 C89215 V.Rajeswari 06/FC 11.2 12900 P-61,L-44,E-5 33 69 20 28.9 7 4.3 NormochromicNormo cytic 
Normal 
Morphology NIL 
20 D003075 N.Prasath 11/MC 9.3 10000 P-56,L-42,E-2 32 63 19 29.8 3.9 4.8 Hypochromic Microcytic 
Normal 
Morphology NIL 
21 D006422 S.Deepikasri 04/FC 10.1 8500 P-64,L-36 31 62.5 18 26 1.7 3.8 Hypochromic Microcytic 
Normal 
Morphology NIL 
22 D003905 J.Pooja 11/FC 12.4 9300 p-53,L-42,E-5 29 72.5 17.8 24.3 2.2 4.2 NormochromicNormo cytic 
Normal 
Morphology NIL 
23 C88373 M.Mathivanan 12/MC 12.3 6300 P-61,L-34,E-5 26.5 69 27.5 34.9 2.8 4.2 NormochromicNormo cytic 
Normal 
Morphology NIL 
24 C98659 E.Motheswaran 07/MC 11.9 9950 P-65,L-31,E-4 35 75 26 33.9 4.7 4.3 NormochromicNormo cytic 
Normal 
Morphology NIL 
25 D008631 F.NaveenSingh 12/MC 12.7 6850 P-61,L-35,E-4 30 34 68.5 34.9 4.5 4.3 NormochromicNormo cytic 
Normal 
Morphology NIL 
26 C099668 E.Dhanusree 10/FC 11.9 7750 P-40,L-53,E-6,M-1 35 16 27 35.7 3.4 4.3 NormochromicNormo cytic 
Normal 
Morphology NIL 
27 C48120 S.AbdhulHalad 05/FC 11.9 8500 p-42,L-52,E-6 31.5 66 19 25.1 2.9 4.2 NormochromicNormo cytic 
Normal 
Morphology NIL 
28 C86040 T.Kaviya 03/FC 11.5 13600 P-34,L-60,E-6,M-1 32 63 14.5 25.5 3 4.3 NormochromicNormo cytic 
Normal 
Morphology NIL 
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BLOOD INVESTIGATION AFTER TREATMENT 
S.No OPD Number  
Name of the    
Patient Age/Sex 
HB-
gm/dL 
TC-
Cells/µl 
DC in %   PCV-
% 
MCV-
fL 
MCH-
pg 
MCHC-
gm/dL 
PLC-
Lakhs/µl 
TRBC-C 
millions/
µl 
SemearStudy Semear 
For MP RBC WBC 
29 C85039 T.Balaji 07/MC 12.5 9300 P-56,L-34,E-I0 37.8 76.3 28.6 37.9 1.4 4.3 NormochromicNormo cytic 
Normal 
Morphology NIL 
30 D006423 S.Datchanasri 04/FC 11.9 10900 P-42,L-39,E-19 31.6 62.5 17.6 25.6 1.9 4 HypochromicMicrocytic 
Normal 
Morphology NIL 
31 C97014 R.E.SanjaKannan 12/MC 11.9 15500 P-34,L-45,E-19,M-2 33.5 72.3 21.8 32.8 4.6 4.6 NormochromicNormo cytic 
Normal 
Morphology NIL 
32 C66400 C.Nivethana 10/FC 12.6 7950 P-48,L-43,E-9 37.9 74.6 27.8 35.9 2.5 4.8 NormochromicNormo cytic 
Normal 
Morphology NIL 
33 C099077 A.AshokKumar 05/MC 11.6 11600 P-35,L-55,E-10 37.3 77.4 28.5 36.9 4.3 4.3 NormochromicNormo cytic 
Normal 
Morphology NIL 
34 C69026 C.Abitha 05/FC 11.5 7700 P-62,L-34,E-4 29.5 33.9 68.8 34.9 4.8 4.2 NormochromicNormo cytic 
Normal 
Morphology NIL 
35 D002812 M.AravindBala 07/MC 12.2 7700 P-37,L-51,E-12 35.3 81.6 28.6 33.8 3.2 4.5 NormochromicNormo cytic 
Normal 
Morphology NIL 
36 D005107 M.Parthiban 06/MC 11.9 6000 P-40,L-55,E-5 37.8 76.8 27.8 34.9 2.6 4 NormochromicNormo cytic 
Normal 
Morphology NIL 
37 C91731 K.Lakshmi 11/FC 13 11500 P-48,L-44,E-11 32.9 70.8 18.8 35.5 3.9 4.8 NormochromicNormo cytic 
Normal 
Morphology NIL 
38 IPD Number 1017 A.Akshaya 09/FC 11.2 7900 P-40,L-57,E-3 34.6 15.6 26.9 35.7 3.6 4.6 
HypochromicM
icrocytic 
Normal 
Morphology NIL 
39 IPD Number 1027 S.Shobana 04/FC 8.2 11000 P-28,L-67,E-5 29.5 33.8 68.6 34.9 4.9 3.6 
HypochromicM
icrocytic 
Normal 
Morphology NIL 
40 C54677 Umapriyaa 10/FC 9 13700 P-36,L-57,E-5,M-2 29.8 62.8 13.9 24.5 3 3.5 HypochromicMicrocytic 
Normal 
Morphology NIL 
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DISCUSSION 
 
Ø In preclinical study the result reveals, the dose level of 180mg/kg bw is highly safety. 
Ø Haematological studies reveals increased level of parameters like Hb% and Rbc 
count. 
Ø From the Clinical Study the following point were taken for discussion. 
 
Sex 
 According to the clinical study, female children were affected more than male 
children. 45% of the cases were found to be male children and 55% were found to be 
female children. But in the Siddha literatures, there is no reference of incidence of pandu 
to a specific sex in children age. 
 
Age 
 The age limit for the cases taken for study ranged from 3 to 12 years. Among the 
affected children 7.5% were found to be within the age limit of 1 - 3 Years. 35% were 
found to be within the age limit of 4 – 6 years and 57.5% were found to be within the age 
limit of 7 – 12 years. 
 
Socio-economic status 
 In this pesent study 65% of cases were belonging to poor socio-economic status. 
Poor socio-economic status is a main predisposing factor, since the poor people usually 
consume low nutritional food. 
 
Paruva Kaalam 
 Most of cases, subjected to this study existed predominantly in kaarkalam and less 
in koothir and venil kaalam. According to the siddha concept, Thannilai valarchi of 
pitham is during kaar kaalam. 
 
Thinai 
 Among 40 cases that were affected, 13 cases are from Kurinji, 6 cases from 
Mullai, 7 cases from Marutham, 14 cases from Neithal Nilam. On doing this study most 
of the anemic children are came from kurinji nilam. 
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Etiology 
Generally Pandu noi is mainly due to dietic factors, which cause vitiation of 
pitham and kabam. History of patients reveals that differential intake of food and food 
habits, worm infestation, excessive intake of ash, soil and clay (h/o pica) wandering in hot 
climate, over intake of salt, sour and pungent food items and malnutritious diet cause this 
disease. 
In modern Paediatrics, the etiology is based upon malnutrition and worm 
infestation. In both systems, it is stated that any factor which causes vitiation of blood 
produce this disease. 
 
Mukkutram 
 Among the three vital forces pitham is mainly affected. That too among the five 
types of pitham, ranjagam is affected which causes discolouration of mucous membrane. 
Also the other forms of pitham such as Analam, sathagam, prasagam are affected in 100% 
of the cases. The derangement of pitham is followed by derangement of kabam and 
vaatham. 
 
Udal Kattugal  
 In this  saaram and senner were affected in 100% of the cases 
 
Ennvagi Theruvukal 
 In this study, the changes of Naadi, sparisam, Naa, Niram, Mozhi, Vizhi, Malam, 
Moothiram are noted. 
 
Naadi 
 According to this study vathapitha naadi was found in 21 cases, pithavaatha naadi 
in 12 cases and pithakaaba naadi in 7 cases. 
 
Sparisam 
 Palpable liver and spleen tenderness may be noted. Palpitation may be noted. The 
skin of the patient should also be noted. 
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Naa 
 In all of the cases, the tongue is pallor in colour 
 
Niram 
 Due to involvement of pitham, the body is pallor in colour. This condition was 
noted in almost all cases. 
 
Mozhi 
 Mostly mozhi is not affected 
 
Vizhi 
 In iron deficiency anaemia, pallor of conjunctiva was noted in almost all cases 
Malam 
 The colour of the stool is pale yellow in colour. According to their study of 
patients were affected by hard stool, constipation. 
 
Moothiram 
 In pandu noi, due to increased state of pitham the urine is yellow or dark yellow in 
colour. 
 
Neikuri 
The neikuri was ring shaped in 27 cases and pearl shaped in 13 cases. 
 The diagnosis was made on the basis of Envagai Thervukal and available modern 
investigation methods. In most of the cases, haemoglobin level, total red blood cells, 
PCV, MCV, MCH, and MCHC are reduced. After treatment there is a tremendous 
increase in the haemoglobin level, total red blood cells, PCV, MCV, MCH, and MCHC. 
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Pharmacological analysis 
 
· Pharmacological analysis review that the drugs possess satisfactory hematinic action 
to treat pandu noi.  
· Results of clinical study reveals the capability of the medicine to treat the pandu noi 
(anemia) Adverse reaction of the medicine was not observed during the coarse of the 
study. 
· qualitative analysis and phytochemical screening showed that the trail medicine 
having iron in both ferric and ferrous forms and the other important minerals which 
are necessary to fulfill its therapeutic value.  
· Results of pharmacological activity had good correlation with the clinical study 
report. 
· At the end of the study the results reveals the exact preparation was selected for the 
disease pandu noi. 
129 
 
SUMMARY 
 
Ø Who defines that “Health is the state of physical, mental social and spirituals 
wellbeing and not merely the absence of disease and infirmity”. 
 
Ø Pandu noi is one of the major global disease in children community.prevelence is 
to be higher in children than adults and elder ones 
 
Ø So the author focus to treat the pandu noi.with the foremost preparation of the 
medicine TIRUDHARATCHATHA CHOORANAM(TC)which is mentioned in 
Agasthiyar vaithiya rathina surukkam.. 
 
Ø The raw drugs were collected from the local market in Chennai. 
 
Ø The medicine was prepared in NIS gunapadam lab. 
 
Ø Then the medicine was subjected to the toxicity study. 
 
Ø After done the preclinical study medicine was subjected to clinical study in NIS, 
OPD and IPD. 
 
Ø Simultaneously the pharmacology activities, qualitative analysis of the medicine 
were evaluated. 
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CONCLUSION 
 
· Based on the preclinical study the safety dose was 1500mg/kg bw, here we 
concluded that the therapeutic dose of TIRUDHARATCHATHA 
CHOORANAM(TC) which is mentioned in Agasthiyar vaithya rathina surukkam 
is a safe dose for clinical trial. 
 
· From the clinical study findings I concluded that the foremost preparation of the 
medicine was selected is effective singnificantly in the management of Pandu noi. 
 
· It could be one of the unavoidable medicine to treat pandu noi. 
 
· In forthcoming days this study will be redouble by do the standardization of the 
medicine. 
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 ANNEXURE  
Profoma 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
An open clinical study on PANDU with 
TIRUDHARATCHATHA CHOORANAM (TC). 
 
CONSENT FORM  
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent/guardian 
Signature  _________________ 
Date   _________________ 
Name  _________________ 
CONSENT BY PARENT 
 I have been informed to my satisfaction, by the attending physician, the purpose 
of the clinical trial, and the nature of drug treatment and follow-up including the 
laboratory investigations to be performed to monitor and safeguard my son/daughter body 
functions. 
 I am aware of my right to opd my son/daughter out of the trail at any time during 
the course of the trail without having to give the reasons for doing so.  
 I, exercising my free power of choice, hereby give my consent to include my 
son/daughter as a subject in the clinical trial of ‘TIRUDHARATCHATHA 
CHOORANAM(TC) for the treatment of ‘PANDU’  
 
Date :       Signature  __________________ 
      Name   __________________ 
Date :       Signature of witness  __________________ 
      Name   __________________ 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI-47 
AYOTHIDOSS PANDITHAR HOSPITAL 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
AN OPEN CLINICAL TRAIL OF SIDDHA DRUGS TIRUDHARATCHATHA 
CHOORANAMAND  FOR THE TREATMENT OF PANDU IN CHILDREN 
 
SELECTION PROFORMA 
 
1. O.P /I.P No :    Bed No:  2. S.NO : 
 
3. Name  :     _______________________ 4. Age (Yr)  : 
 
5. Gender  : M   F 
 
6. Father’s Name          :  
 
7. Father’s Occupation  : 
  
8. Mother’s Name        : 
 
9. Monthly/Annual Income     : 
 
10. Religion                            :  
 
11. Socio Economical Level   : 
 
12. Informant                         :   Mother      Father   Guardian 
 
13. Postal Address   : ________________________________________  
  
      _________________________________________ 
  
133 
 
      _________________________________________ 
    
    Contact No. _______________________________ 
 
14. Complaints and duration  : ________________________________________ 
 
    _________________________________________ 
 
    _________________________________________ 
 
15. History of present illness  : ________________________________________ 
 
16. Past History   : ________________________________________ 
 
17. Immunization History  : ________________________________________ 
 
 
18. Family History   : 1. No     2. Yes     
 
 
19. Food Habits  : 1. Veg   2. Non Veg  3. Mixed     
 
 
GENERAL EXAMINATION 
 
 
20. Body weight (Kg)  :  
 
 
21. Height (Cms)  :  
 
 
22. Body temperature ( F ) :  
 
134 
 
 
23. Heart rate/minute  :  
 
 
24. Respiratory rate/minute :  
 
 
25. Pulse rate/minute  : 
 
      1. YES   2. NO 
 
 
26. Pallor   :  
 
 
27. Jaundice   : 
 
 
28. Clubbing   : 
 
 
29. Cyanosis   : 
 
 
30. Pedal Oedema  : 
 
 
31. Lymphadenopathy : 
 
 
32. H/o Pica   :  
 
 
33. Engorged veins  :  
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34. Abdominal Distension : 
 
 
35. Congenital Abnormalities : 
 
 
36. Jugular Venous Pulsation :  
 
 
EXAMINATION OF VITAL ORGANS 
 
37. CVS  Normal  Abnormal 
 
 
38. RS   Normal  Abnormal 
 
 
39. Abdomen  Normal  Abnormal 
 
 
CLINICAL ASSESMENT :  1. YES  2. NO 
 
 
40. Lassitude    :  
 
 
41. Fatigue    :  
 
 
42. Breathlessness on exertion : 
 
 
43. Palpitation    : 
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44. Pallor of skin and mucous membrane : 
 
 
45. Tachycardia    : 
 
 
46. Anorexia     : 
 
 
47. Irritability     : 
 
 
48. Lack of interest    : 
 
 
49. Koilonychia     : 
 
 
50. Angular stomatitis   : 
 
 
51. Dyspnoea on exertion   : 
 
 
52. Recurrent infection   : 
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CLINICAL EXAMINATION 
 
53. INSPECTION  : ________________________________________ 
 
      _________________________________________ 
 
54. PALPATION  : ________________________________________ 
 
      _________________________________________ 
 
55. PERCUSSION  : ________________________________________ 
 
      _________________________________________ 
 
56. AUSCULTATION : ________________________________________ 
 
      _________________________________________ 
 
SIDDHA METHODS OF EXAMINATION 
 
57. Nilam  
 
1. Kurinji   2. Mullai   3.Marutham 
 
4. Neithel  5. Paalai     
 
 
58. Kaala Iyalbu    
 
1. Kaarkalam    2.  Koothirkaalam 
 
3   Munpanikaalam   4. Pinpanikaalam 
 
5 Illavenirkaalam   6. Muthuvenirkaalam 
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59. Yaakai  
 
1. Vatham   2. Vatha pitham  3. Vatha Kabam 
 
4.   Pitham   5. Pitha vatham  6. Pitha Kabam 
 
7.   Kabam   8. Kaba vatham  9. Kaba pitham 
 
 
60. Gunam   
 
1. Sathuvam   2. Rasatham   3. Thamasam    
 
 
PORI PULANGAL 
     
1. Normal  2. Affected 
 
61. Mei        _______________ 
  
62. Vaai        _______________ 
 
63. Kan        _______________ 
 
64. Mooku        _______________ 
 
65. Sevi        _______________ 
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KANMENDHIRIUM / KANMAVIDAYAM 
 
1. Normal  2. Affected  
 
66. Kai        _______________ 
 
67. Kaal        _______________ 
 
68. Vaai        _______________ 
 
69. Eruvai        _______________ 
 
70. Karuvai        _______________ 
 
UYIR THATHUKKAL 
 
VATHAM :   1. Normal  2. Affected 
 
71. Pranam        _______________ 
 
72. Abanam        _______________ 
 
73. Viyanan        _______________ 
 
74. Uthanan        _______________ 
 
75. Samanan        _______________ 
 
76. Nagan        _______________ 
 
77. Koorman        _______________ 
 
78. Kirukaran        _______________ 
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79. Devathathan       _______________ 
 
80. Dhananjeyan       _______________  
         
 
PITHAM   1. Normal  2. Affected  
 
81. Analam        _______________ 
 
82. Ranjagam        _______________ 
 
83. Saathagam        _______________ 
 
84. Alosagam        _______________ 
 
85. Prasagam        _______________ 
 
 
KABAM   1. Normal  2. Affected 
 
86. Avalambagam       _______________ 
 
87. Kilethagam       _______________ 
 
88. Pothagam        _______________ 
 
89. Tharpagam       _______________ 
 
90. Santhigam        _______________ 
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UDAL THATHUKKAL   1. Normal   2. Affected 
 
91. Saaram        _______________ 
 
92. Senneer        _______________ 
 
93. Oon        _______________ 
 
94. Kozhuppu        _______________ 
 
95. Enbu        _______________ 
 
96. Moolai        _______________ 
 
97. Sukilam / Suronitham      _______________ 
 
 
ENVAGAI THERVUGAL 
    1. Normal  2. Affected 
 
98. Naa        _______________ 
 
99. Niram        _______________ 
 
100. Mozhi        _______________ 
 
101. Vizhi        _______________ 
 
102. Sparisam        _______________ 
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MALAM   1. Normal  2. Affected 
 
103. Niram        _______________ 
 
104. Edai        _______________ 
 
105. Nurai        _______________ 
 
106. Elagal        _______________ 
 
107. Erugal        _______________ 
 
 
MOOTHIRAM 
 
Neer kuri   1. Normal  2. Affected 
 
108. Niram        _______________ 
 
109. Edai        _______________ 
 
110. Manam        _______________ 
 
111. Nurai        _______________ 
 
112. Enjal        _______________ 
 
113. Nei kuri         
 
 1. Vatham   2. Pitham  3. Kabam  4. Others 
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114. Naadi 
 1. Vatham  2.Vatha pitham  3. Vatha kabam 
 
 4. Pitham  5. Pitha vatham  6. Pitha kabam 
 
 7. Kabam  8. Kaba vatham  9. Kaba pitham 
 
 
LAB INVESTIGATION 
 Blood : 
 
115. Hb (gm %) 
 
116. Total RBC 
 
117. Smear study 
 
118. PCV 
 
119. MCV 
 
120. MCHC 
 
121. MCH 
 
122. TC (cells / cumm ) 
 
123.Platelet count 
 
124.MP:  
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DC (%) 
 
123. L     124. N    125. M 
 
126. E    127. B 
 
128. ESR (mm) ½ Hr    129. ESR (mm) 1 Hr 
 
URINE 
 
130. Albumin  - Nil   +  ++         +++ 
 
131. Sugar  - Nil   +  ++  +++ 
 
DEPOSIT 
     1. Absent  2. Present   
 
132. Pus cells      ___________________ 
 
133. Epithelial cells      ___________________ 
 
134. Red blood cells       ___________________ 
 
135. Casts / Crystal                                                                        ___________________  
                                                                
136.Bile Salts                                                                                  ___________________  
 
137.Bile Pigments                                                                          ___________________  
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MOTION 
 
136. Ova  ___________________ 
 
137. Cyst  ___________________ 
 
138. Occult blood  ___________________ 
 
 
INCLUSION CRITERIA 
       1. Yes  2. No 
 
139. Aged 3 year to 12 years   
 
140. Hb level with < 11 gm/dl  for aged 3-6 years 
 and < 12 gm/dl for aged 7-12 years patients 
 
141.Willing to give blood sample for the 
         Investigation when required 
 
142. Smear showing hypochromic microcytic 
        Anaemia 
 
143. pallor of skin, mucous membrane,  
conjunctiva, nail beds, 
 
EXCLUSION CRITERIA 
 
144. Jaundice 
 
145. Malaria 
 
146. Inherited defects 
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147. Congenital Heart Diseases 
 
148. Patient with chronic disease 
 
149.  Smear not showing Hypochromic 
        microcytic anaemia 
 
150. Patient not willing to give  
blood sample for investigation. 
Admitted to trial   1. Yes    2. No 
 
151. If yes, S.No: 
 
152. Date  : ___________________ 
 
153. Station : ___________________  
 
 
 
 Signature of Doctor 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI-47 
AYOTHIDOSS PANDITHAR HOSPITAL 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
AN OPEN CLINICAL TRAIL OF SIDDHA DRUGS TIRUDHARATCHATHA 
CHOORANAM FOR THE TREATMENT OF PANDU 
 
ASSESSMENT PROFORMA 
 
 
 
1. O.P/I.P No  :         Bed No:  2. S.NO : 
 
3. Name  :     _______________________  
 
4. Date of Admission  : 
 
5. Date of this Assessment : 
 
6. Day of Assessment  :  
 
 
CLINICAL ASSESMENT :  1. YES  2. NO 
 
 
7. Lassitude     :  
 
 
8. Fatigue     :  
 
 
9. Breathlessness on exertion   : 
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10. Palpitation     : 
 
 
11. Pallor of skin and mucous membrane : 
 
 
12. Tachycardia    : 
 
 
13. Anorexia     : 
 
 
14. Irritability     : 
 
 
15. Lack of interest    : 
 
 
16. Koilonychia     : 
 
 
17. Angular stomatitis   : 
 
 
18. Dyspnoea on exertion   : 
 
 
19. Recurrent infection   : 
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CLINICAL EXAMINATION 
 
20. INSPECTION  : __________________________________________ 
 
     __________________________________________ 
 
21. PALPATION  : __________________________________________ 
 
     __________________________________________ 
 
22. PERCUSSION  : __________________________________________ 
 
     __________________________________________ 
 
23. AUSCULTATION : __________________________________________ 
 
     __________________________________________ 
 
TEST IN SIDDHA ASPECTS 
 
ENVAGAI THERVUGAL 
   1. Normal 2.Affected 
 
24. Naa      ___________________________ 
 
25. Niram      ___________________________ 
 
26. Mozhi      ___________________________ 
 
27. Vizhi      ___________________________ 
 
28. Sparisam      __________________________ 
 
150 
 
MALAM 
   1. Normal 2.Affected 
 
29. Niram    ___________________________ 
 
30. Edai      ___________________________ 
 
31. Nurai      ___________________________ 
 
32. Elagal      ___________________________ 
 
33. Erugal      ___________________________ 
 
MOOTHIRAM 
 
Neer kuri  1. Normal 2.Affected 
 
34. Niram      ___________________________  
 
35. Edai      ___________________________ 
 
36. Manam      ___________________________ 
 
37. Nurai      ___________________________ 
 
38. Enjal      ___________________________ 
 
39. Nei kuri 
 
 1. Vatham   2. Pitham  3. Kabam  4. Others 
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40. Naadi 
 1. Vatham  2.Vatha pitham  3. Vatha kabam 
 
 4. Pitham  5. Pitha vatham  6. Pitha kabam 
 
 7. Kabam  8. Kaba vatham  9. Kaba pitham 
 
 
LAB INVESTIGATION 
  
Blood: 
 
41. Hb (gm %) 
 
42. Total RBC 
 
43.  Smear study 
 
44. PCV 
 
45. MCV 
 
46. MCH 
 
47. MCHC 
 
48. TC (cells / cumm ) 
 
49 Platelet Count 
 
50 MP  
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 DC (%) 
 
51. L     50. N    51. M 
 
52. E    53. B 
 
53. ESR (mm) ½ Hr    55. ESR (mm) 1 Hr 
 
 
URINE 
 
54. Albumin  - Nil   +  ++  +++ 
 
55. Sugar  - Nil   +  ++  +++ 
 
 
DEPOSIT 
     1. Absent  2. Present   
 
56. Pus cells ___________________ 
 
57. Epithelial cells ___________________ 
 
58. Red blood cells  ___________________ 
 
59. Casts / Crystal                                                                      ___________________ 
 
60.Bile salts                                                                                ___________________ 
 
61.Bile Pigments ___________________ 
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MOTION 
 
62. Ova ___________________ 
 
63. Cyst ___________________ 
 
64. Occult blood ___________________ 
 
65. RESULT 
 
 1. Good  2. Moderate  3.Mild 
 
66. Date  ________________ 
 
67. Station ________________   
 
         Signature of Doctor 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600047. 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
An open clinical study on PANDU with  TIRUDHARATCHATHA 
CHOORANAM(TC). 
 
WITHDRAWAL FORM 
 
Name :      OPD/IPD No:     
       
Age     :      Reg.No         : 
 
 
Date of trial commencement           : 
 
Date of withdrawal from trial         : 
 
 
Reasons for withdrawal                                          
 
1.Long absence at reportinging                  : 
 
2.Irregular treatment                              : 
 
3.Shift of locality                                         : 
 
4.complication/Adverse reactions if any        : 
 
5.exaribation of symptoms                             : 
 
6.patient not willing to continue                                  
 
 
 
 
Sign of lecturer                                                                                  sign of the principal  
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